Zedge Inc.

11/19/2026 | Press release | Distributed by Public on 11/19/2026 14:06

Preliminary Proxy Statement (Form PRE 14A)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

________________

SCHEDULE 14A

________________

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934

Filed by the Registrant

☒

Filed by a Party other than the Registrant

☐

Check the appropriate box:

☒

Preliminary Proxy Statement

☐

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐

Definitive Proxy Statement

☐

Definitive Additional Materials

☐

Soliciting Material under Rule 14a-12

Zedge, Inc.
(Name of Registrant as Specified in Its Charter)

_________________________________________________________________

(Name of Person(s) Filing Proxy Statement if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒

No fee required.

☐

Fee paid previously with preliminary materials.

☐

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

ZEDGE, INC.
1178 Broadway, 3rd Floor #1450
New York, New York 10001
(330) 577-3424

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

TIME AND DATE:

12:00 p.m., Eastern Standard Time, on Thursday, January 14, 2027

PLACE:

Insperity Conference Room, 1177 6th Avenue, 35th floor, New York, New York 10036

ITEMS OF BUSINESS:

1. To elect six directors, each for a term of one year.

2. To approve the adoption of the Zedge, Inc. 2026 Equity Incentive Plan and an amendment to increase the number of shares of the Company's Class B Common Stock available for the grant of awards thereunder to 1,538,695 shares.

3. To approve the issuance of the Company's Class B Common Stock warrants issued in the Company's September 2026 private placement and the shares of the Company's Class B Common Stock issuable upon their exercise.

4. To ratify the appointment of UHY LLP as the Company's independent registered public accounting firm for the Fiscal Year ending July 31, 2027.

5. To transact other business as may properly come before the Annual Meeting of Stockholders and any adjournment or postponement thereof.

RECORD DATE:

You can vote if you were a stockholder of record as of the close of business in New York, New York on November 17, 2026.

PROXY VOTING:

You can vote either in person at the Annual Stockholders Meeting or by proxy without attending the meeting. See details under the heading "How do I Vote?"

ANNUAL STOCKHOLDERS MEETING IN-PERSON ADMISSION:

If you were a stockholder of record as of the close of business in New York, New York on November 17, 2026, a form of personal photo identification must be presented in order to be admitted to the Annual Stockholders Meeting. If your shares are held in the name of a bank, broker or other holder of record, you must bring a brokerage statement or other written proof of ownership as of November 17, 2026 with you to the Annual Stockholders Meeting, as well as a form of personal photo identification. The Company requests that any stockholder seeking to attend the Annual Stockholders Meeting in person first email the Company's investor relations department at [email protected] to RSVP.

ANNUAL STOCKHOLDERS MEETING DIRECTIONS:

You may request directions to the Annual Stockholders Meeting via email at [email protected] or by calling Zedge Investor Relations at (330) 577-3424.

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR
THE ZEDGE, INC. ANNUAL STOCKHOLDERS MEETING TO BE HELD ON JANUARY 14, 2027:
The Notice of Annual Meeting of Stockholders and Proxy Statement and the Fiscal 2026 Annual Report are available at:
http://investor.zedge.net

BY ORDER OF THE BOARD OF DIRECTORS

Joyce J. Mason

Corporate Secretary

New York, New York
November [__], 2026

ZEDGE, INC.
1178 Broadway, 3rd Floor #1450
New York, New York 10001
(330) 577-3424

_________________________

PROXY STATEMENT

_________________________

GENERAL INFORMATION

Introduction

This Proxy Statement is furnished to the stockholders of record of Zedge, Inc., a Delaware corporation (the "Company" or "Zedge"), as of the close of business in New York, New York on November 17, 2026, in connection with the solicitation, by the Company's Board of Directors (the "Board of Directors"), of proxies for use in voting at the Company's 2027 Annual Meeting of Stockholders (the "Annual Stockholders Meeting"). The Annual Stockholders Meeting will be held on Thursday, January 14, 2027, at 12:00 p.m., Eastern Standard Time, in the Insperity Conference Room, 1177 6th Avenue, 35th floor, New York, New York 10036. The shares of the Company's Class A common stock, par value $0.01 per share ("Class A Common Stock"), and Class B Common Stock, par value $0.01 per share ("Class B Common Stock"), present at the Annual Stockholders Meeting or represented by the proxies received by Internet or mail (properly marked, dated and executed) and not revoked, will be voted at the Annual Stockholders Meeting. This Proxy Statement is being mailed to the Company's stockholders starting on or about December 2, 2026.

Solicitation and Voting Procedures

This solicitation of proxies is being made by the Company. The solicitation is being conducted by mail and by e-mail, and the Company will bear all attendant costs. These costs will include the expense of preparing and mailing proxy materials for the Annual Stockholders Meeting and any reimbursements paid to brokerage firms and others for their expenses incurred in forwarding the solicitation materials regarding the Annual Stockholders Meeting to the beneficial owners of Class A Common Stock and Class B Common Stock. The Company may conduct further solicitations personally, by telephone or by facsimile through its officers, directors and employees, none of whom will receive additional compensation for assisting with the solicitation.

The close of business in New York, New York on November 17, 2026 has been fixed as the record date (the "Record Date") for determining the holders of shares of Class A Common Stock and Class B Common Stock entitled to notice of, and to vote at, the Annual Stockholders Meeting. As of the close of business on the Record Date, the Company had 15,522,789 shares outstanding and entitled to vote at the Annual Stockholders Meeting, consisting of 524,775 shares of Class A Common Stock and 14,998,014 shares of Class B Common Stock.

Stockholders are entitled to three votes for each share of Class A Common Stock held by them and one-tenth of one vote for each share of Class B Common Stock held by them. The holders of Class A Common Stock and Class B Common Stock will vote as a single body on all matters presented to the stockholders. There are no dissenters' rights of appraisal in connection with any proposal.

How do I Vote?

You can vote either in person at the Annual Stockholders Meeting or by proxy without attending the meeting.

Beneficial holders of Class A Common Stock and Class B Common Stock as of the close of business in New York, New York on the Record Date whose shares of stock are held of record by another party should receive voting instructions from their bank, broker or other holder of record. If a stockholder's shares are held through a nominee and the stockholder wants to vote at the meeting, such stockholder must obtain a proxy from the nominee record holder authorizing such stockholder to vote at the Annual Stockholders Meeting.

1

Stockholders of record should receive a paper copy of our proxy materials and may vote by following the instructions on the proxy card that is included with the proxy materials. As set forth on the proxy card, there are two convenient methods for holders of record to direct their vote by proxy without attending the Annual Stockholders Meeting: on the internet or by mail. To vote by internet, visit www.voteproxy.com. To vote by mail, mark, date and sign the enclosed proxy card and return it in the postage-paid envelope provided. Holders of record may also vote by attending the Annual Stockholders Meeting and voting by ballot.

All shares for which a proxy has been duly executed and delivered (by internet or mail) and not properly revoked prior to the meeting will be voted at the Annual Stockholders Meeting. If a stockholder of record signs and returns a proxy card but does not give voting instructions, the shares represented by that proxy will be voted as recommended by the Board of Directors. If any other matters are properly presented at the Annual Stockholders Meeting for consideration, the persons named as proxies will have the discretion to vote on those matters for you, to the extent permitted by applicable law. On the date of filing this Proxy Statement with the Securities and Exchange Commission (the "SEC"), the Board of Directors did not know of any other matter to be raised at the Annual Stockholders Meeting.

How Can I Change My Vote?

A stockholder of record can revoke his, her or its proxy at any time before it is voted at the Annual Stockholders Meeting by delivering to the Company (to the attention of Joyce J. Mason, Esq., Corporate Secretary), 1178 Broadway, 3rd Floor #1450, New York, New York 10001, a written notice of revocation or by executing a later-dated proxy by Internet or mail, or by attending the Annual Stockholders Meeting and voting in person.

If your shares are held in the name of a bank, broker, or other nominee, you must obtain a proxy executed in your favor from the holder of record (that is, your bank, broker, or nominee) to be able to vote at the Annual Stockholders Meeting.

Quorum and Vote Required

The presence at the Annual Stockholders Meeting of a majority of the voting power of outstanding Class A Common Stock and Class B Common Stock (voting together as a single class), either in person or by proxy, will constitute a quorum for the transaction of business at the Annual Stockholders Meeting. Abstention votes and any broker non-votes (i.e., votes withheld by brokers on non-routine proposals in the absence of instructions from beneficial owners) will be counted as present or represented at the Annual Stockholders Meeting for purposes of determining whether a quorum exists.

The affirmative vote of a majority of the voting power of shares that are voted on a relevant proposal at the Annual Stockholders Meeting will be required for the approval of the election of any director (Proposal No. 1), the adoption of the Company's 2026 Equity Incentive Plan and an amendment thereto (the Company's 2026 Equity Incentive Plan as amended and restated to date, the "2026 Plan") (Proposal No. 2), the approval of the issuance of the Company's Class B Common Stock warrants issued in the Company's September 2026 private placement (the "Warrants") and the shares of the Company's Class B Common Stock issuable upon their exercise (the "Warrant Shares") (Proposal No. 3), and the ratification of the appointment of the Company's independent registered public accounting firm for the Fiscal Year ending July 31, 2027 (Proposal No. 4). This means that the number of votes cast "for" a Proposal must exceed the number of votes cast "against" that Proposal. Abstentions are not counted as votes "for" or "against" a nominee or any of these proposals. The purchasers in the September 2026 private placement have agreed not to vote their shares on Proposal No. 3, and those shares will not be counted as votes cast on that proposal. See "Proposal No. 3 - Voting Restrictions and Vote Required.

If you are a beneficial owner whose shares are held of record by a broker, you must instruct your broker how to vote your shares. If you do not provide voting instructions, your shares will not be voted on any proposal on which the broker does not have discretionary authority to vote. This is called a "broker non-vote." In these cases, the broker can register your shares as being present at the Annual Stockholders Meeting for purposes of determining the presence of a quorum but will not be able to vote on those matters for which specific authorization is required under the rules of the New York Stock Exchange American ("NYSE American"). In the event of a broker non-vote with respect to any proposal coming before the Annual Stockholders Meeting or in the event of an abstention with respect to Proposal No. 1, Proposal No. 2, Proposal No. 3, or Proposal No. 4, the shares represented by the relevant proxy will

2

not be deemed to be present and entitled to vote on that proposal for the purpose of determining the total number of shares of which a majority is required for adoption, having the practical effect of reducing the number of affirmative votes required to achieve a majority vote for such matters by reducing the total number of shares from which a majority is calculated.

If you are a beneficial owner whose shares are held of record by a broker, your broker does not have discretionary authority to vote on the election of directors (Proposal No. 1), the adoption of the 2026 Plan (Proposal No. 2), the approval of the issuance of the Warrants and Warrant Shares (Proposal No. 3), or on any stockholder proposal or other matter raised at the Annual Stockholders Meeting without instructions from you, in which case a broker non-vote will occur and your shares will not be voted on these matters. However, if you are a beneficial owner whose shares are held of record by a broker, your broker has discretionary voting authority under NYSE American rules to vote your shares on the ratification of the Company's independent registered public accounting firm for the Fiscal Year ending July 31, 2027 (Proposal No. 4), even if the broker does not receive voting instructions from you.

How Many Votes Are Required to Approve Other Matters?

Unless otherwise required by law or the Company's Bylaws, the affirmative vote of a majority of the voting power represented at the Annual Stockholders Meeting and entitled to vote will be required for other matters that may properly come before the meeting.

Stockholders Sharing the Same Address

We are sending only one copy of the Annual Report and Proxy Statement to stockholders of record who share the same last name and address, unless they have notified the Company that they want to continue to receive multiple copies. This practice, known as "householding," is designed to reduce duplicate mailings and printings and postage costs. However, if any stockholder residing at such address wishes to receive a separate Annual Report or Proxy Statement in the future, he or she may contact Joyce J. Mason, Esq., Corporate Secretary, Zedge, Inc., 1178 Broadway, 3rd Floor #1450, New York, New York 10001, or by phone at (973) 438-3500 and we will promptly forward to such stockholder a separate Annual Report and/or Proxy Statement. The contact information above may also be used by members of the same household currently receiving multiple copies of the Annual Report and Proxy Statement in order to request that only one set of materials be sent in the future.

References to Fiscal Years

The Company's fiscal year ends on July 31st of each calendar year. Each reference to a fiscal year refers to the fiscal year ending in the calendar year indicated (e.g., Fiscal 2026 refers to the fiscal year ended July 31, 2026).

3

CORPORATE GOVERNANCE

Introduction

The Company has in place a comprehensive corporate governance framework that reflects the corporate governance requirements and the rules and regulations promulgated under the Securities Exchange Act of 1934 (the "Exchange Act"), as amended, and the corporate governance-related listing requirements of the NYSE American. Consistent with the Company's commitment to strong corporate governance, the Company does not rely on the exceptions from the NYSE American's listing requirements related to corporate governance available to it because it is a "controlled company".

In accordance with applicable sections of the NYSE American Company Guide, the Company has adopted a set of Corporate Governance Guidelines and a Code of Business Conduct and Ethics, the full texts of which are available for your review in the Corporate Governance section of our website at http://investor.zedge.net/ZDGE/corporate_governance and which also are available in print to any stockholder upon written request to the Corporate Secretary.

The Company qualifies as a "controlled company" as defined by the NYSE American Company Guide, because more than 50% of the voting power of the outstanding capital stock of the Company is controlled by one individual, Michael Jonas, who serves as our Executive Chairman and Chairman of the Board. Notwithstanding that being a "controlled company" entitles the Company to exempt itself from the requirement imposed by the NYSE American Company Guide that the Compensation Committee and Corporate Governance and Nominating Committee be comprised entirely of independent directors, the Board of Directors has determined affirmatively that the Compensation Committee and the Corporate Governance and Nominating Committee are in fact comprised entirely of independent directors, as defined by the NYSE American Company Guide and Corporate Governance Guidelines. The directors have been nominated by the Corporate Governance and Nominating Committee, including the nominees under "Proposal No. 1 - Election of Directors" below. See "The Corporate Governance and Nominating Committee" section, below.

Director Independence

The Corporate Governance Guidelines adopted by the Board of Directors provide that 50% or more of the members of the Board of Directors, and each member of the Audit, Compensation and Corporate Governance and Nominating Committees, must meet the independence requirements set forth therein. The full text of the Corporate Governance Guidelines, including the independence requirements, is available for your review in the Corporate Governance section of our website at http://investor.zedge.net/ZDGE/corporate_governance. For a director to be considered independent, the Board of Directors must determine that a director meets the Independent Director Qualification Standards set forth in the Corporate Governance Guidelines, which comply with the NYSE American Company Guide definitions of independence, and is free from any material relationship with the Company and its executive officers. The Board of Directors considers all relevant facts and circumstances known to it in making an independence determination, and not merely from the standpoint of the director, but also from that of persons or organizations with which the director has an affiliation or significant financial interest. In addition to considering all relevant information available to it, the Board of Directors uses the following categorical Independent Director Qualification Standards in determining the "independence" of its directors:

1. During the past three years, the Company shall not have employed the director, or, except in a non-officer capacity, any of the director's immediate family members;

2. During the past three years, the director shall not have received, and shall not have an immediate family member who has received, during any twelve-month period within the last three years, more than $120,000 in direct compensation from the Company, other than director and committee fees and pension or other forms of deferred compensation for prior service (provided such compensation is not contingent in any way on continued service);

3. (a) The director shall not be a current partner or employee of a firm that is the Company's internal or external auditor, (b) the director shall not have an immediate family member who is a current partner of such firm, (c) the director shall not have an immediate family member who is a current employee of such firm and personally works on the Company's audit, and (d) neither the director nor any of his or her immediate family members shall have been, within the last three years, a partner or employee of such firm and personally worked on the Company's audit within that time;

4

4. Neither the director, nor any of his or her immediate family members, shall be, or shall have been within the last three years, employed as an executive officer of another company where any of the Company's present executive officers at the same time serves or served on that company's compensation (or equivalent) committee; and

5. The director shall not be a current employee and shall not have an immediate family member who is a current executive officer of a company (excluding tax-exempt organizations) that has made payments to, or received payments from, the Company for property or services in an amount which, in any of the last three fiscal years, exceeds the greater of (a) $1,000,000 or (b) two percent of the consolidated gross revenues of such other company. The Corporate Governance and Nominating Committee will review the materiality of such relationship to tax-exempt organizations to determine if such director qualifies as independent.

In addition, all members of the Company's Audit Committee must meet the independence requirements of Section 10A-3 of the Securities Exchange Act of 1934, as amended, which are set forth in the Audit Committee Charter.

Based on the review and recommendation of the Corporate Governance and Nominating Committee, the independent directors have determined that each of Mark Ghermezian, Elliot Gibber, Paul Packer and Gregory Suess is independent in accordance with the Corporate Governance Guidelines and the Audit Committee Charter and, thus, that more than 50% of the current Board of Directors, more than 50% of the director nominees, and each member or nominee intended to become a member of the Audit Committee, Compensation Committee and Corporate Governance and Nominating Committee, is independent.

As used herein, the term "non-employee director" shall mean any director who is not an employee or consultant of the Company, and who is deemed to be independent by the Board of Directors. Therefore, neither Howard S. Jonas nor Michael Jonas is a non-employee director.

When determining independence, the Corporate Governance and Nominating Committee considered the following relationship:

• Activist Artists, the stock of which is 32.05% owned by Gregory Suess, has a referral agreement with the Company through which the Company pays Activist Artists $5,000 per month, plus possible commissions. The Company paid Activist Artists a total of $60,000 in Fiscal 2026. The Corporate Governance and Nominating Committee determined that this referral agreement does not impinge on Mr. Suess' independence in his service as a director.

Director Selection Process

The Corporate Governance and Nominating Committee will consider director candidates recommended by the Company's stockholders. Stockholders may recommend director candidates by contacting the Chairman of the Board, whose contact information is provided below under the heading "Director Communications." The nominees under "Proposal No. 1 - Election of Directors" were nominated by the Corporate Governance and Nominating Committee. See "The Corporate Governance and Nominating Committee" section, below.

The Corporate Governance and Nominating Committee considers candidates suggested by its members, senior management and stockholders in anticipation of upcoming elections and actual or expected board vacancies. All candidates, including those recommended by stockholders, are evaluated on the same basis in light of the entirety of their credentials and the needs of the Board of Directors and the Company. Of particular importance is the candidate's wisdom, integrity, ability to make independent analytical inquiries, understanding of the business environment in which the Company operates, as well as his or her potential contribution to the diversity of the Board of Directors and his or her willingness to devote adequate time to fulfill duties as a director. Under "Proposal No. 1 - Election of Directors" below, an overview of each nominee's experience, qualifications, attributes and skills is provided that led the Corporate Governance and Nominating Committee to determine that each nominee should serve as a director.

5

Director Communications

Stockholders and other interested parties may communicate with (i) the Board of Directors, by contacting the Chairman of the Board, (ii) the non-employee directors, by contacting the Lead Independent Director (currently Mark Ghermezian), or (iii) the Audit, Compensation or Corporate Governance and Nominating Committees of the Board of Directors by contacting the respective Chairs of such committees. All communications should be in writing, should indicate in the address whether it is intended for the Chairman of the Board, the Lead Independent Director, or a Committee Chair, and should be directed care of Zedge, Inc.'s Corporate Secretary, Stockholder Communications, Zedge, Inc., 1178 Broadway, 3rd Floor #1450, New York, New York 10001.

The Corporate Secretary will relay correspondence (i) intended for the Board of Directors, to the Chairman of the Board, who will, in turn, relay such correspondence to the entire Board of Directors, (ii) intended for the non-employee directors to the Lead Independent Director, and (iii) intended for the Audit, Compensation, and Corporate Governance and Nominating Committees to the Chairs of such committees.

The Corporate Secretary may filter out and disregard (without providing a copy to the directors or advising them of the communication), or may otherwise handle at his or her discretion, any director communication that is described by one of the following categories:

• Obscene materials

• Unsolicited marketing or advertising material or mass mailings

• Unsolicited newsletters, newspapers, magazines, books and publications

• Surveys and questionnaires

• Resumes and other forms of job inquiries

• Requests for business contacts or referrals

• Material that is threatening or illegal

• Any communications or materials that are not in writing

In addition, the Corporate Secretary may handle in his or her discretion any director communication that can be described as an "ordinary business matter." Such matters include the following:

• Routine questions, service and product complaints and comments that can be appropriately addressed by management

• Routine invoices, bills, account statements and related communications that can be appropriately addressed by management

6

BOARD OF DIRECTORS AND COMMITTEES

Board of Directors

On May 23, 2016, each of Michael Jonas, Howard S. Jonas and Mark Ghermezian was elected as a director and each of them continues to serve as a director. Paul Packer was elected as a director on April 1, 2020 and continues to serve as a director. Elliot Gibber and Gregory Suess were elected as directors on August 5, 2020 and continue to serve as directors. Elliot Gibber was also a director from January 17, 2018 until November 7, 2019.

Upon recommendation of the Corporate Governance and Nominating Committee, the Board nominated each of Michael Jonas, Howard S. Jonas, Mark Ghermezian, Elliot Gibber, Paul Packer and Gregory Suess for re-election as a director.

The Board of Directors held five meetings in Fiscal 2026. In Fiscal 2026, each of the directors, other than Michael Jonas, attended or participated in 75% or more of the aggregate of (i) the total number of regularly scheduled meetings of the Board of Directors held during the period in which each such director served as a director and (ii) the total number of regularly scheduled meetings held by all committees of the Board of Directors during the period in which each such director served on such committees.

Directors are encouraged to attend the Company's annual meeting of stockholders, in person or via video link. All of the current members of the Board of Directors attended the 2026 annual meeting of stockholders either in person or telephonically.

Board of Directors Leadership Structure and Risk Oversight Role

Our Chairman of the Board, Michael Jonas, provides overall leadership to the Board of Directors. The Board recognizes that one of its key responsibilities is to evaluate and determine its optimal leadership structure so as to provide independent oversight of management. The Board understands that there is no single, generally accepted approach to providing Board leadership, and that given the dynamic and competitive environment in which we operate, the optimal Board leadership structure may vary as circumstances warrant. The Board has determined that, given Michael Jonas' leadership skills, relationships with the members of management and other members of the Board, and prior positions in which he acted as a leader and provided oversight over different governing organizations, he is well suited to be the Chairman of the Board at the present time. Michael Jonas has been Chairman of the Board since November 14, 2016 and Executive Chairman since October 18, 2017. He also served as Interim Chief Executive Officer from August 31, 2019 until November 7, 2019. Howard S. Jonas, the father of Michael Jonas, has been the Vice-Chairman of the Board since November 14, 2016, and served as Chairman of the Board from June 2, 2016 until November 14, 2016.

The Board of Directors as a whole, and through its committees, has responsibility for the oversight of risk management, including the review of the policies with respect to risk management and risk assessment. The risk management oversight roles of the Audit Committee, Compensation Committee and Corporate Governance and Nominating Committee (each of which is comprised solely of independent directors), discussed below, provide an appropriate and effective balance to the role of the Chairman of the Board. With the oversight of the full Board of Directors, the Company's management is responsible for the day-to-day management of the material risks the Company faces. The Board of Directors is required to satisfy to itself that the risk management process implemented by management is adequate and functioning as designed.

The NYSE American Company Guide requires that the non-employee directors of the Company meet at least annually in executive session without the presence of non-independent directors and management. These executive sessions are held at every regularly scheduled meeting of the Board of Directors.

Mr. Ghermezian, an independent director, has served as the "Lead Independent Director" since June 2, 2016 and has been elected to that post annually by vote of the non-employee directors.

As stated above, each of the Audit Committee, Compensation Committee and Corporate Governance and Nominating Committee oversees certain aspects of risk management and reports its respective findings to the full Board of Directors on a quarterly basis, and as is otherwise needed. The Audit Committee is responsible for overseeing risk management of financial matters, financial reporting, the adequacy of the risk-related internal controls, internal investigations and security risks. The Compensation Committee oversees risks related to compensation policies and practices. The Corporate Governance and Nominating Committee oversees our Corporate Governance Guidelines and governance-related risks, such as board independence, as well as senior management succession planning.

7

Board Committees

The Board of Directors has established an Audit Committee, a Compensation Committee, and a Corporate Governance and Nominating Committee.

The Audit Committee

The Audit Committee currently consists of Messrs. Suess (Chairman), Gibber and Packer. The Audit Committee operates under a written Audit Committee charter adopted by the Board of Directors, which can be found in the Corporate Governance section of our web site, http://investor.zedge.net/ZDGE/corporate_governance, and is also available in print to any stockholder upon request to the Corporate Secretary. The principal duties of the Audit Committee under its written charter include: (i) responsibilities associated with our external and internal audit staffing and planning; (ii) accounting and financial reporting issues associated with our financial statements and filings with the SEC; (iii) financial and accounting organization and internal controls; (iv) auditor independence and approval of non-audit services; and (v) "whistle-blower" procedures for reporting questionable accounting and audit practices. The Audit Committee held four meetings during Fiscal 2026.

The Board of Directors has determined that (i) all of the members of the Audit Committee are independent within the meaning of the applicable NYSE American listing standards and the Sarbanes-Oxley Act of 2002, (ii) all of the members of the Audit Committee are financially literate, and (iii) Mr. Suess qualifies as an "audit committee financial expert," as determined by the Board of Directors in accordance with SEC rules.

The Compensation Committee

The Compensation Committee currently consists of Messrs. Gibber (Chairman), Ghermezian and Packer. The Compensation Committee operates under a written charter adopted by the Board of Directors, which can be found in the Corporate Governance section of our web site, http://investor.zedge.net/ZDGE/corporate_governance, and which is also available in print to any stockholder upon request to the Corporate Secretary. The Compensation Committee is responsible for, among other things, reviewing, evaluating and approving all compensation arrangements for the executive officers of the Company, evaluating the performance of executive officers, administering the Company's 2026 Equity Incentive Plan, as amended and restated, and its predecessor, the 2016 Stock Option and Incentive Plan, as amended and restated, and recommending to the Board of Directors the nature and amount of the compensation for Board members, such as retainers, committee and other fees, stock option, restricted stock, deferred stock and other stock awards, and other similar compensation as deemed appropriate. The Compensation Committee confers with the Company's executive officers when making the above determinations. The Compensation Committee held five meetings during Fiscal 2026. The Board of Directors has determined that all of the members of the Compensation Committee are independent within the applicable NYSE American listing standards.

The Corporate Governance and Nominating Committee

The Corporate Governance and Nominating Committee currently consists of Messrs. Ghermezian (Chairman), Gibber and Packer. The Corporate Governance and Nominating Committee operates under a written charter adopted by the Board of Directors, which can be found in the Corporate Governance section of our web site, http://investor.zedge.net/ZDGE/corporate_governance, and which is also available in print to any stockholder upon request to the Corporate Secretary. The Corporate Governance and Nominating Committee is responsible for, among other things, reviewing and reporting to the Board of Directors on matters involving relationships among the Board of Directors, the stockholders and senior management. The Corporate Governance and Nominating Committee (i) reviews the Corporate Governance Guidelines and other policies and governing documents of the Company and recommends revisions as appropriate, (ii) reviews any potential conflicts of interest of independent directors, (iii) reviews related person transactions, and (iv) determines director independence, and makes recommendations to the Board of Directors regarding director independence. The Corporate Governance and Nominating Committee held five meetings in Fiscal 2026. The Board of Directors has determined that all of the members of the Corporate Governance and Nominating Committee are independent within the applicable NYSE American listing standards.

The Corporate Governance and Nominating Committee is responsible for overseeing nominations to the Board of Directors, including: (i) developing the criteria and qualifications for membership on the Board of Directors; (ii) recommending candidates to fill new or vacant positions on the Board of Directors; and (iii) conducting appropriate inquiries into the backgrounds of potential candidates.

8

FISCAL 2026 COMPENSATION FOR NON-EMPLOYEE DIRECTORS

Annual compensation for non-employee directors for Fiscal 2026 was comprised of cash and equity compensation, consisting of awards of fully vested restricted shares of Class B Common Stock. Mark Ghermezian, Elliot Gibber, Paul Packer and Gregory Suess were the only non-employee directors during Fiscal 2026, all of whom served as non-employee directors during all of Fiscal 2026. Each of Messrs. Ghermezian, Gibber, Packer and Suess is a current non-employee director.

As set by the Compensation Committee, each director of the Company who is deemed to be independent receives $70,000, to be paid on each January 5th (or the next business day thereafter) for the prior 12 months, payable half in cash and half in fully vested restricted shares of Class B Common Stock.

Payments of non-employee directors' fees are paid in January following attendance of at least 75% of the regularly scheduled Board of Directors meetings during the preceding 12-month period, and, when applicable for non-employee directors who joined the Board of Directors in such prior 12-month period, are pro-rated based on the calendar quarter in which such director joined the Board of Directors provided that such director attended at least 75% of the regularly scheduled board meetings for such partial period. For any non-employee director who departed from the Board of Directors during the prior 12-month period, directors' fees are paid in January, and are pro-rated based on the number of calendar quarters that such director was a member of the Board of Directors, if such director attended 75% of the regularly scheduled board meetings for such partial period.

The Chairman of the Board may, in his or her discretion, waive the requirement of at least 75% attendance by a director to receive the annual cash compensation in the case of mitigating circumstances. Directors are not entitled to additional compensation for serving on standing committees of the Board of Directors and are not entitled to per-meeting fees.

During Fiscal 2026, pursuant to the 2016 Plan, on January 5, 2026, the Company granted 12,027 shares of Class B Common Stock (which were fully vested upon grant) and paid $35,000 in cash to each of Messrs. Ghermezian, Gibber, Packer and Suess for service as a non-employee director for the 12-month period ended December 31, 2025.

Director Board Retainers

Other than as described above, a retainer is not paid for serving as a non-employee director.

Committee Fees

No directors receive fees for committee service or serving as chairs of committees.

Lead Independent Director

The Lead Independent Director (currently Mr. Ghermezian) does not receive an additional fee for serving in such position.

Fiscal 2026 Director Compensation Table

The following table lists compensation for any person who served as a non-employee director during Fiscal 2026. This table does not include compensation to Howard S. Jonas or Michael Jonas, as they were not non-employee directors and did not receive any compensation for their service as directors during Fiscal 2026.

Name

Dates of Board Service
During Fiscal 2026

Fees
Earned or
Paid in
Cash
($)

Stock
Awards
($)

All Other
Compensation
($)

Total
($)

Mark Ghermezian

08/01/2025 - 07/31/2026

35,000

35,000

​(1)

0

70,000

Elliot Gibber

08/01/2025 - 07/31/2026

35,000

35,000

​(1)

0

70,000

Paul Packer

08/01/2025 - 07/31/2026

35,000

35,000

​(1)

0

70,000

Gregory Suess

08/01/2025 - 07/31/2026

35,000

35,000

​(1)

0

70,000

____________

(1) Represents the grant-date fair value of awards of 12,027 fully vested restricted shares of Class B Common Stock issued on January 5, 2026, computed in accordance with FASB ASC Topic 718.

9

RELATED PERSON TRANSACTIONS

Review of Related Person Transactions

The Board of Directors has adopted a Statement of Policy with respect to Related Person Transactions, which is administered by the Corporate Governance and Nominating Committee. This policy covers any transaction or series of transactions in which the Company or a subsidiary is a participant, the amount involved exceeds $120,000 and a Related Person has a direct or indirect material interest ("Related Person Transaction"). Related Persons include directors, director nominees, executive officers, any beneficial holder of more than 5% of any class of the Company's voting securities, and any immediate family member of any of the foregoing persons. The policy also covers transactions which, despite not meeting all of the criteria set forth above, would otherwise be considered material to investors based on qualitative factors, as determined by the Corporate Governance and Nominating Committee with input from the Company's management and advisors. Transactions that fall within the definition of a Related Person Transaction are considered by the Corporate Governance and Nominating Committee for approval or other action. Based on its consideration of all of the relevant facts and circumstances, the Corporate Governance and Nominating Committee will decide whether or not to approve such transactions and will approve only those transactions that are in the best interests of the Company and its stockholders. If the Company becomes aware of an existing Related Person Transaction that has not been approved under this policy, the matter will be referred to the Corporate Governance and Nominating Committee at its next regularly scheduled meeting or to the Chairman of the Corporate Governance and Nominating Committee prior to such meeting. The Corporate Governance and Nominating Committee will evaluate all options available, including ratification, revision or termination of such transaction.

Transactions with Related Persons, Promoters and Certain Control Persons; Certain Relationships

There is a father/son relationship between Howard S. Jonas, a director and Vice Chairman of the Board, and Michael Jonas, Chairman of the Board, Executive Chairman and controlling stockholder of the Company. Michael Jonas' total compensation during Fiscal 2026 is set forth in the Summary Compensation table below.

The Company and IDT Corporation entered into a Transition Services Agreement (the "TSA"), effective June 1, 2016. Howard S. Jonas is the Vice Chairman of the Board of the Company and the Chairman of the Board of IDT Corporation. Since October 25, 2016, the Company has been controlled by Michael Jonas, the son of Howard S. Jonas. Michael Jonas has been a member of our Board of Directors since May 23, 2016, Chairman of the Board since November 14, 2016 and Executive Chairman since October 18, 2017. Pursuant to the TSA, IDT provides legal services to the Company. The Company paid IDT a total of $131,000 for legal services provided by IDT pursuant to the TSA during Fiscal 2026. In addition, IDT paid the Company $89,000 for consulting services provided to IDT by a Company employee. As of July 31, 2026, the Company owed IDT $9,000 for services provided by IDT pursuant to the TSA.

In 2018, the Company and IDT entered into a revenue sharing agreement, pursuant to which the Company receives 15% of the net profits generated from the advertising revenue from kiosks in certain bodegas served by IDT's National Retail Services ("NRS") business. This constitutes a Related Person Transaction because Howard Jonas serves as a director of both Zedge and IDT. During Fiscal 2026, the Company received no revenue under this agreement.

On June 19, 2024, the Company entered into a revenue sharing agreement with NRS, whereby Zedge and its partially or wholly-owned subsidiaries, Emojipedia and GuruShots, provide a selection of their digital content for display on NRS' screens and share in the revenue generated from the resulting advertisements. This constitutes a Related Person Transaction because Howard Jonas serves as a director of both Zedge and IDT. In Fiscal 2026, the Company received $17,000 under this agreement. As of July 31, 2026, NRS owed the Company $2,000.

On September 10, 2026, after the end of Fiscal 2026, the Company granted Michael Jonas options to purchase 386,244 shares of Class B Common Stock, subject to stockholder approval of the adoption of the 2026 Equity Incentive Plan and an amendment increasing the number of shares available for issuance thereunder. See "Executive Compensation - Option Grant After Fiscal Year-End" and Proposal No. 2 for a description of the grant and the required stockholder approval.

10

In September 2026, after the end of Fiscal 2026, the Company completed a private placement with Elliot Gibber, a director of the Company, Chartwell Holding LLC ("Chartwell") and a third investor. Howard S. Jonas and his wife are the sole beneficiaries of Chartwell and Mr. Jonas is deemed to beneficially own the securities held by Chartwell. Chartwell purchased 2,218,430 shares of Class B Common Stock and warrants to purchase 1,996,587 additional shares for $6,500,000. Mr. Gibber purchased 221,843 shares of Class B Common Stock and warrants to purchase 199,659 additional shares for $650,000. Chartwell and Mr. Gibber paid $2.93 per share and accompanying warrant coverage, and their warrants have an exercise price of $3.22 per share. The third investor paid $2.98 per share and accompanying warrant coverage, and its warrants have an exercise price of $3.28 per share. The warrants may not be exercised until the later of stockholder approval required under applicable NYSE American rules and six months after their respective issuance dates. See Proposal No. 3 for additional information regarding the warrants and the requested stockholder approval.

11

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth certain information regarding the beneficial ownership of shares of Class A Common Stock and Class B Common Stock by (i) each person known by the Company to be the beneficial owner of more than 5% of the outstanding shares of Class A Common Stock or Class B Common Stock, (ii) each of the Company's directors, director nominees, and Named Executive Officers (who are listed in the "Executive Compensation" section, below), and (iii) all directors, Named Executive Officers and executive officers of the Company as a group. Unless otherwise noted in the footnotes to the table, to the best of the Company's knowledge, the persons named in the table have sole voting and investing power with respect to all shares indicated as being beneficially owned by them.

Unless otherwise noted, the security ownership information provided below is given as of the close of business on November 17, 2026 and all shares are owned directly. Percentage ownership information is based on 524,775 shares of Class A Common Stock and 14,998,014 shares of Class B Common Stock outstanding. The ownership figures reported for Michael Jonas (including the information for all directors, Named Executive Officers and other executive officers as a group) assume the conversion of all 524,775 currently outstanding shares of Class A Common Stock (all of which are owned by Michael Jonas) into an equal number of shares of Class B Common Stock.

Name

Number of
Shares of
Class B
Common
Stock

Percentage of
Ownership of
Class B
Common
Stock

Percentage of
Aggregate
Voting Power
δ

Michael Jonas

2,046,487

​(1)

13.2

%

56.2

%

Jonathan Reich

261,442

​(2)

1.7

%

*

Yi Tsai

68,018

​(3)

*

*

Howard S. Jonas

2,344,805

​(4)

15.6

%

7.6

%

Mark Ghermezian

16,590

​(5)

*

*

Elliot Gibber

491,952

​(6)

3.3

%

1.5

%

Paul Packer

158,541

​(7)

1.1

%

*

Gregory Suess

72,283

*

*

All directors, Named Executive Officers and other executive officers as a group - 9 persons(8)

5,460,118

​(9)

34.7

%

66.6

%

____________

* Less than 1%.

δ Voting power represents combined voting power of Class A Common Stock (three votes per share) and Class B Common Stock (one-tenth of one vote per share). Excludes stock options which have no voting rights.

(1) Consists of: (a) 524,775 shares of Class A Common Stock (which are convertible into shares of Class B Common Stock on a one-for-one basis) held by Michael Jonas directly; and (b) 1,521,712 shares of Class B Common Stock held by Michael Jonas directly, including 38,736 unvested restricted shares. Does not include 386,244 shares of Class B Common Stock underlying stock options granted to Michael Jonas on September 10, 2026, which vest in three equal annual installments, provided that no installment will vest prior to stockholder approval of the 2026 Plan (see Proposal No. 2). None of such options are currently exercisable or exercisable within 60 days of the date this Proxy Statement is being distributed.

(2) Consists of: (a) 92,946 shares of Class B Common Stock held by Mr. Reich directly; (b) 128,546 shares of Class B Common Stock issuable upon the exercise of stock options currently exercisable or exercisable within 60 days of the date this Proxy Statement is being distributed; and (c) 39,950 shares of Class B Common Stock held by Mr. Reich in his account in the Company's 401(k) plan.

(3) Consists of: (a) 6,570 shares of Class B Common Stock held by Mr. Tsai directly; (b) 37,998 shares of Class B Common Stock issuable upon the exercise of stock options currently exercisable or exercisable within 60 days of the date this Proxy Statement is being distributed, and (c) 23,450 shares of Class B Common Stock held by Mr. Tsai in his account in the Company's 401(k) plan.

(4) Consists of: (a) 2,218,430 shares of Class B Common Stock held by Chartwell Holding LLC; (b) 60,495 shares of Class B Common Stock held by the Debbie Y. Jonas 2018 Dynasty Trust; and (c) 65,880 shares of Class B Common Stock owned by the Jonas Foundation. The foregoing does not include: (a) 1,996,587 shares of Class B Common Stock issuable upon the exercise of warrants held by Chartwell Holding LLC, which are not exercisable until the later of (i) stockholder approval of the issuance of such warrants and shares (see Proposal No. 3) and (ii) March 25, 2027; (b) 57,251 shares of Class B Common Stock owned by the Howard S. and Deborah Jonas Foundation, Inc., as Howard S. Jonas does not beneficially own these shares; and (c) 53,333 shares of Class B Common Stock owned by 2012 Jonas Family, LLC (of which Howard S. Jonas is a minority equity holder).

12

(5) Consists of: (a) 12,027 shares of Class B Common Stock held by Mr. Ghermezian directly; and (b) 4,563 shares of Class B Common Stock owned by T5 Capital Partners LLC.

(6) Consists of: (a) 461,952 shares of Class B Common Stock held by Mr. Gibber directly; and (b) 30,000 shares of Class B Common Stock issuable upon the exercise of stock options that are currently exercisable or exercisable within 60 days of the date this Proxy Statement is being distributed. Does not include 199,659 shares of Class B Common Stock issuable upon the exercise of warrants, which are not exercisable until the later of (i) stockholder approval of the issuance of such shares (see Proposal No. 3) and (ii) March 11, 2027.

(7) Consists of: (a) 63,660 shares of Class B Common Stock; and (b) 94,881 shares of Class B Common Stock held by Globis Capital Partners, L.P.

(8) Includes Morris Berger, who became the Company's Chief Executive Officer on October 1, 2026. Does not include 465,684 shares of Class B Common Stock underlying stock options granted to Mr. Berger on October 28, 2026, which vest ratably in twenty quarterly installments, provided that no installment will vest prior to stockholder approval of the amendment to the Company's 2026 Equity Incentive Plan (see Proposal No. 2). None of such options are currently exercisable or exercisable within 60 days of the date this Proxy Statement is being distributed.

(9) Consists of the shares and options set forth above with respect to the Named Executive Officers, Morris Berger and directors (including Michael Jonas' shares of Class A Common Stock, which are convertible into shares of Class B Common Stock on a one-for-one basis).

13

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Under the securities laws of the United States, the Company's directors, executive officers, and any persons holding more than ten percent or more of a registered class of the Company's equity securities are required to file reports of ownership and changes in ownership, on a timely basis, with the SEC. Based on material provided to the Company, the Company believes that all such required reports were filed on a timely basis in Fiscal 2026.

14

EXECUTIVE COMPENSATION

Summary Compensation Table

The table below summarizes the total compensation paid or awarded by the Company for performance during Fiscal 2026 and Fiscal 2025 to each of the Company's Chief Executive Officer and its other two executive officers (the "Named Executive Officers").

Name and Principal Position

Fiscal
Year

Salary
($)
(1)

Bonus
($)
(1)

Stock
Awards
($)
(2)

Option
Awards
($)
(2)

All Other
Compensation
($)

Total
($)

Jonathan Reich

2026

375,000

124,313

-

-

14,000

​(4)

513,313

Chief Executive Officer and President

2025

375,000

124,313

83,855

​(3)

13,800

​(4)

596,968

Michael Jonas

2026

-

​(5)

50,000

-

-

-

50,000

Executive Chairman and Chairman of the Board

2025

-

​(5)

50,000

54,894

​(6)

-

-

104,894

Yi Tsai

2026

230,000

80,000

-

-

12,458

​(4)

322,458

Chief Financial Officer

2025

215,000

80,000

25,934

​(7)

-

11,805

​(4)

332,739

____________

† Mr. Reich served as the Company's Chief Executive Officer and President throughout Fiscal 2026. Effective October 1, 2026, he became the Company's Chief Operating Officer and President and Morris Berger became the Company's Chief Executive Officer.

(1) The Company's executive compensation structure is designed to attract and retain qualified and motivated personnel and align their interests with those of the Company and its stockholders. The Named Executive Officers are awarded bonuses and/or equity awards based on certain accomplishments in respect of the relevant fiscal year. The Company does not target any specific proportion of total compensation in setting annual base salary, bonus compensation and equity awards. Cash bonuses include amounts paid in a subsequent fiscal year for services during the fiscal year in question. Executive officers are eligible for bonuses, in cash or equity, as determined by the Compensation Committee. Except as provided for in employment agreements that the Company has entered into or may enter into with its executive officers, any bonus compensation to executive officers will be determined by our Compensation Committee based on factors it deems appropriate, including, without limitation, the achievement of specific performance targets and our financial and business performance. The Compensation Committee adopts fiscal year goals and objectives, for the Company and for each executive officer, to be used as a guide when determining annual bonus payments to executive officers after the end of the fiscal year. Such goals may be Company-wide or targeted at specific segments, business units or corporate departments. The Compensation Committee reviews the performance of the Company relative to those goals and objectives, and the contribution of each executive officer to such performance at the end of the fiscal year and/or otherwise and considers them as some of the factors when determining the amounts of annual and/or other bonuses to be awarded to executive officers. Equity awards may include both time-based and performance-based vesting criteria, including criteria linked to operational or market price achievements which further align the interests of the executive officers with our stockholders.

(2) The amounts shown in these columns reflect the aggregate grant-date fair value of restricted stock awards, deferred stock units ("DSUs") and option awards computed in accordance with FASB ASC Topic 718. In valuing such awards, the Company made certain assumptions. For a discussion of those assumptions, please see Note 12 - Stock-Based Compensation to the Company's Consolidated Financial Statements included in its Annual Report on Form 10-K for the Fiscal Year ended July 31, 2026. Holders of restricted shares of Class B Common Stock are entitled to receive any dividends paid on Class B Common Stock. Stock Awards include the value of stock awards made in a subsequent fiscal year for services during the fiscal year in question.

(3) Represents the aggregate grant-date fair value of a grant of 19,400 DSUs granted to Mr. Reich on January 21, 2025. Each DSU represents the right to receive between 1/3 of a share and 3 shares of Class B Common Stock. The DSUs vested or are scheduled to vest as follows: 6,466 vested on September 8, 2025; 6,467 vested on September 7, 2026 and 6,467 are scheduled to vest on September 6, 2027. The number of shares that will be issued for each DSU vested will depend on the market price for the Class B Common Stock as of the relevant vesting date. If that market price is less than $2.76 (the baseline value of a share of Class B Common Stock at the time the grant was approved), 1/3 of a share will be issued per DSU; if the price is $7.00 or greater, 3 shares will be issued per DSU. For prices between $2.76 and $7.00, the number of shares issued will be proportionate based on six distinct market price bands. Upon vesting in full, Mr. Reich will be entitled to receive between 4,311 and 38,802 shares of Class B Common Stock.

(4) Represents the value of shares of Class B Common Stock contributed by the Company as a matching contribution under the Company's 401(k) Plan.

15

(5) Michael Jonas' base salary is paid in the form of restricted shares of Class B Common Stock that vest ratably over a three-year period. The full grant-date fair value of each such grant is reported in the Stock Awards column for the fiscal year in which the grant is made, and accordingly no amounts are reported in the Salary column for Mr. Jonas for Fiscal 2026 or Fiscal 2025. Michael Jonas' most recent grant of restricted shares as compensation for base salary (for Fiscal 2024 - Fiscal 2026) was a grant of 116,208 restricted shares of Class B Common Stock on February 8, 2024 (which had a grant-date fair value of $380,000), 38,736 shares vested on each of February 7, 2025 and February 9, 2026, and 38,736 shares are scheduled to vest on February 8, 2027.

(6) Represents the aggregate grant-date fair value of 12,700 DSUs granted to Michael Jonas on January 21, 2025. Each DSU represents the right to receive between 1/3 of a share and 3 shares of Class B Common Stock as set forth in footnote 3 above. 4,233 of the DSUs vested on each of September 8, 2025 and September 7, 2026; and 4,234 of the DSUs are scheduled to vest on September 6, 2027. Upon vesting in full, Michael Jonas will be entitled to receive between 2,822 and 25,401 shares of Class B Common Stock.

(7) Represents the aggregate grant-date fair value of a grant of 6,000 DSUs granted to Mr. Tsai on January 21, 2025. Each DSU represents the right to receive between 1/3 of a share and 3 shares of Class B Common Stock as set forth in footnote 3 above. 2,000 of the DSUs vested on each of September 8, 2025 and September 7, 2026 and 2,000 of the DSUs are scheduled to vest on September 6, 2027. Upon vesting in full, Mr. Tsai will be entitled to receive between 1,333 and 12,000 shares of Class B Common Stock.

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth all equity awards made to each of the Named Executive Officers that were outstanding at the end of Fiscal 2026.

Option Awards

Stock Awards

Name

Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable

Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable

Option
Exercise
Price
($)

Option
Expiration
Date

Number of
Shares or
Units of Stock
That Have
Not Vested
(#)

Market
Value of
Shares or
Units of
Stock
That Have
Not Vested
($)
(1)

Equity
Incentive
Plan Awards:
Number of
Unearned
Shares,
Units or
Other Rights
That Have
Not Vested
(#)

Equity
Incentive
Plan Awards:
Market or
Payout Value
of Unearned
Shares, Units or
Other Rights
That Have Not
Vested ($)
(1)

Jonathan Reich(4)

60,000(5)

-

2.27

​(2)

09/28/2026

-

-

12,934

​(6)

38,155

4,898

-

2.27

​(2)

11/26/2027

60,000

-

1.965

11/06/2029

30,000

-

1.60

01/12/2030

33,648

-

1.44

10/18/2030

Michael Jonas

-

-

-

-

38,736

​(3)

114,271

8,467

​(7)

24,978

Yi Tsai

19,998

-

1.965

11/06/2029

-

-

4,000

​(8)

11,800

3,000

-

1.44

10/18/2030

15,000

-

2.27

​(2)

12/06/2030

____________

(1) Market value is computed by multiplying the closing market price of one share of Class B Common Stock on July 31, 2026, the last day that the stock was traded on the NYSE American in Fiscal 2026 ($2.95), by the number of restricted shares of Class B Common Stock that had not vested as of July 31, 2026. The market or payout value of unearned DSUs is computed by multiplying that closing market price by the number of shares of Class B Common Stock that would be issued for those DSUs at the market price band in effect on July 31, 2026 (one share per DSU).

(2) On October 20, 2022, the Board unanimously approved the repricing of all outstanding and unexercised stock options granted under the 2016 Plan with exercise prices above the then current market value held by then current employees, executive officers, and consultants of the Company (the "Eligible Stock Options"). Effective October 20, 2022, the exercise price of all Eligible Stock Options was reduced to $2.27, the closing price of the Company's Class B Common Stock on the NYSE American on October 19, 2022.

(3) Consists of 38,736 unvested restricted shares of Class B Common Stock, granted on February 8, 2024 as compensation for base salary, which are scheduled to vest on February 8, 2027.

(4) Amounts in the Outstanding Equity Awards table reflect that 181,616 options previously granted to Mr. Reich on November 1, 2011 were exercised during the fiscal year ended July 31, 2026 and that 132,226 shares were withheld for cashless exercise and tax purposes, which reduced the number of shares of Class B Common Stock issued to Mr. Reich to 49,390 shares.

(5) Consists of options to purchase 60,000 shares of Class B Common Stock granted to Mr. Reich on September 29, 2016 and exercised on September 28, 2026, of which 50,471 shares were withheld for cashless exercise and tax purposes, which reduced the number of shares of Class B Common Stock issued to Mr. Reich to 9,529 shares.

16

(6) Consists of unvested DSUs granted on January 21, 2025, of which 6,466 vested on September 8, 2025, 6,467 vested on September 7, 2026 and 6,467 are scheduled to vest on September 6, 2027. Each DSU represents the right to receive between 1/3 of a share and 3 shares of Class B Common Stock, depending on the market price of the Class B Common Stock on the vesting date, as described in footnote 3 to the Summary Compensation Table.

(7) Consists of unvested DSUs granted on January 21, 2025, of which 4,233 vested on each of September 8, 2025 and September 7, 2026 and 4,234 are scheduled to vest on September 6, 2027. Each DSU represents the right to receive between 1/3 of a share and 3 shares of Class B Common Stock, as described in footnote 3 to the Summary Compensation Table.

(8) Consists of unvested DSUs granted on January 21, 2025, of which 2,000 vested on each of September 8, 2025 and September 7, 2026 and 2,000 are scheduled to vest on September 6, 2027. Each DSU represents the right to receive between 1/3 of a share and 3 shares of Class B Common Stock, as described in footnote 3 to the Summary Compensation Table.

Policies and Practices Related to the Timing of Grants of Certain Equity Awards

It is the Compensation Committee's practice to consider and approve annual equity grants for the Company's executive officers at its regularly scheduled meeting held in November of each year. At this meeting, the Compensation Committee approves the portion of each named executive officer's annual equity award that will be granted in the form of stock options, if any.

The Company does not schedule its equity grants in anticipation of the release of material, non-public information ("MNPI"), nor does the Company time the release of MNPI based on equity grant dates. In the event MNPI becomes known to the Compensation Committee prior to granting an equity award, the Compensation Committee will take the existence of such information into consideration and use its collective business judgment to determine whether to delay the grant of equity to avoid any impropriety.

During Fiscal 2026, no named executive officer received a stock option grant during the period beginning four business days before, and ending one business day after, the filing of a periodic report on Form 10-Q or Form 10-K or the filing or furnishing of a current report on Form 8-K that discloses MNPI.

Employment Agreements and Potential Payments upon Termination or Change in Control

The following summarizes material executive employment and equity arrangements and benefits payable upon termination of employment or a change in control.

Employment Agreements

Jonathan Reich

On October 14, 2026, the Company entered into an employment agreement with Jonathan Reich, effective October 1, 2026, in connection with his transition from Chief Executive Officer and President to President and Chief Operating Officer. The agreement has a three-year term expiring on September 30, 2029, unless earlier terminated. It provides for an annual base salary of $390,000, with an adjustment retroactive to August 1, 2026 (which is consistent with Company policy regarding annual changes to executive compensation), and increases of $15,000 on each subsequent July 31 during the term.

Mr. Reich is entitled to an annual performance bonus of not less than $124,313 beginning with Fiscal 2026, payable when other officer bonuses are paid and no later than January 31 following the fiscal year for which it is earned.

The employment agreement also provides for the grant of a combination of restricted stock and DSUs under the 2026 Plan representing, in the aggregate, 100,000 shares of Class B Common Stock, to be granted within 150 days after October 1, 2026. One-twelfth of the granted interests will vest on grant and the balance in eleven substantially equal quarterly installments, with full vesting on October 1, 2029. The award has not yet been granted. See Proposal No. 3.

Michael Jonas

Michael Jonas's base salary is paid in restricted shares of Class B Common Stock, as described in footnote 5 to the Summary Compensation Table. Other than the equity grant instruments effectuating the grants described in this Proxy Statement, Michael Jonas has no written or unwritten employment, severance or change-in-control arrangement with the Company.

17

Yi Tsai

Yi Tsai's salary and bonus for Fiscal 2026 are described in the Summary Compensation Table. Mr. Tsai has no written or unwritten scheduled increase, minimum bonus, severance or change-in-control arrangement with the Company.

Morris Berger

Morris Berger became Chief Executive Officer on October 1, 2026. He is party to an employment agreement with the Company, dated September 29, 2026 that expires on September 30, 2029, unless earlier terminated. The agreement provides for an annual salary of $450,000, a $50,000 signing bonus of which $25,000 has been paid and the balance is payable after the first anniversary of his start date.

On October 28, 2026, the Company granted Mr. Berger ten-year nonqualified options to purchase 465,684 shares of Class B Common Stock at $2.56 per share. The options vest in twenty equal quarterly installments over five years commencing October 1, 2026. subject to stockholder approval of the share-increase amendment to the 2026 Plan. Options due to vest prior to such approval shall vest on the first scheduled vesting date following stockholder approval. See Proposal No. 3.

Potential Payments upon Termination

Jonathan Reich

The following summarizes separation pay and acceleration of vesting under Mr. Reich's employment agreement.

Termination event

Separation pay

100,000 Share Award

Termination by the Company without Cause (other than the events listed below), or resignation for Good Reason

Two years' base salary at termination plus a prorated minimum bonus for the fiscal year in which his employment terminates, in 52 installments

Full acceleration of vesting

Death or Disability

Two years' base salary at termination, in 52 installments

No acceleration under the employment agreement

Resignation without Good Reason; non-renewal of employment agreement; or termination by the Company before September 30, 2029 upon a Board determination of material failure in performance

Eighteen months' base salary at termination, in 39 installments

No acceleration under the employment agreement

Termination by the Company for Cause

No separation pay

No acceleration under the employment agreement

Separation benefits require timely execution of a release acceptable to the Company and that the release not be revoked or breached.

For a termination other than for Cause, and subject to the release and applicable election, payment and eligibility conditions, Mr. Reich is also entitled to reimbursement of the Company's portion of health-continuation premiums for up to 24 months.

"Cause" includes specified misconduct, felony indictment, willful or negligent acts or omissions resulting in civil or criminal penalties, and certain failures to perform duties or material breaches that remain uncured after written notice and a 20-day cure period.

"Good Reason" includes a material reduction in title or duties without consent, a material reduction in base salary or minimum bonus, requiring Mr. Reich to report to anyone other than directly to the Chief Executive Officer, or a material breach of the employment agreement by the Company, subject to Mr. Reich providing notice within 30 days of the initial occurrence and a 30-day cure period.

18

Morris Berger

Upon termination by the Company without Cause or resignation for Good Reason, Mr. Berger's employment agreement provides full acceleration of his options. If such termination occurs before September 30, 2029, he also receives one year of base salary at termination in 26 installments, subject to timely execution of an acceptable release that is not revoked or breached.

"Cause" includes specified misconduct, commission of an act constituting a felony, a willful or negligent act or omission resulting in a civil or criminal penalty, willful or continued failure to substantially perform duties after written notice (other than due to physical or mental illness), or material breaches.

"Good Reason" includes a material reduction in duties without consent, a material reduction in compensation, or requiring Mr. Berger to report to anyone other than directly to the Executive Chairman or the Board, subject to Mr. Berger giving written notice within 30 days after the condition first arises. If the Company does not cure the condition in all material respects within 30 days after receiving notice, he must give written notice of resignation within 75 days after the condition first arose.

Option Grant After Fiscal Year End

On September 10, 2026, the Company granted Michael Jonas ten-year nonqualified options under the 2026 Plan to purchase 386,244 shares of Class B Common Stock at $2.93 per share. The options vest in three equal installments of 128,748 shares on September 9, 2027, September 8, 2028 and September 7, 2029. The grant is conditioned on stockholder approval of adoption of the 2026 Plan; no options may be exercised before stockholder approval. See Proposal No. 3.

Equity Awards upon Termination or Change in Control

Under the 2026 option agreements with Michael Jonas and Mr. Berger, vested options generally remain exercisable for 180 days after termination of continuous service, including death, Disability or Retirement, subject to earlier expiration, any different period prescribed by the Compensation Committee and any controlling employment agreement. The option agreements incorporate the terms of the 2026 Plan and the terms of the applicable employment agreement.

The 2026 Plan permits the Compensation Committee to accelerate, substitute, cancel or cash out awards in connection with a Change in Control; the Plan does not itself require automatic acceleration. See the "Description of the 2026 Plan - Change of Control" in Proposal No. 3. The individual contractual acceleration rights described above apply in accordance with the applicable employment agreements.

Outstanding awards under the 2016 Plan remain governed by that plan and their award agreements. The 2016 Plan generally provides automatic full vesting and exercisability immediately before a Corporate Transaction or Change in Control, as defined in that plan, with applicable restrictions on restricted stock and deferred stock units lapsing. Options generally terminate upon consummation of a Corporate Transaction unless the Compensation Committee determines otherwise or the successor or its parent assumes them. Specified dispositions of a related entity may also trigger acceleration, subject to the Plan's exceptions.

Unvested restricted stock and deferred stock units under the 2016 Plan are generally forfeited when service terminates before vesting, subject to applicable exceptions.

Retirement Benefits

The Company maintains a 401(k) plan for eligible U.S. employees that permits pre-tax and after-tax salary deferrals and provides enhanced safe harbor matching contributions. Employee contributions and the Company's safe harbor matching contributions are fully vested. For Fiscal 2026, the Company made its matching contributions in shares of Class B Common Stock. The value of the matching contributions for Messrs. Reich and Tsai is included in the "All Other Compensation" column of the Summary Compensation Table.

19

Pay vs. Performance

The following table presents compensation information for Jonathan Reich, our chief executive officer and principal executive officer ("PEO") during Fiscal 2024 - Fiscal 2026, and the average compensation information for the other individuals named in the summary compensation table, as well as certain measures relating to Company performance.

(a)
Fiscal Year(1)

(b)
Summary
Compensation
Table Total for
PEO
(2) ($)

(c)
Compensation
Actually
Paid to PEO

($)

(d)
Average
Summary
Compensation
Table Total for
Non-PEO
Named
Executive
Officers
(6) ($)

(e)
Average
Compensation
Actually Paid
to Non-PEO
Named
Executive
Officers

($)

(f)
Value of
Initial
Fixed $100
Investment
Based
on Total
Shareholder
Return
(10) ($)

(g)
Net (loss)
Income
(in thousands)
($)

Fiscal 2026

513,313

502,423

​(3)

186,229

141,644

​(7)

143.79

(131

)

Fiscal 2025

596,968

635,191

​(4)

218,817

237,788

​(8)

191.43

(2,392

)

Fiscal 2024

513,814

527,585

​(5)

362,923

406,197

​(9)

172.38

(9,171

)

____________

(1) Information provided for the last three completed fiscal years.

(2) Jonathan Reich, Chief Executive Officer.

(3) In Fiscal 2026, the compensation actually paid to Mr. Reich was $10,890 less than the total amount disclosed in the Summary Compensation Table, due to a decrease in that amount for the change in fair market value from Fiscal 2025 year-end to the vesting date of 6,466 DSUs that were granted prior to Fiscal 2026 that vested during Fiscal 2026.

(4) In Fiscal 2025, compensation actually paid to Mr. Reich was higher than the total amount disclosed in the Summary Compensation Table, due to the following:

a. An increase in the amount of $41,621 for the change in the fair market value from Fiscal 2024 year-end to Fiscal 2025 year-end of the Class B Common Stock underlying awards granted prior to Fiscal 2025 that were outstanding and unvested as of Fiscal 2025 year-end, consisting of 19,400 outstanding and unvested deferred stock units ("DSUs") that increased in fair market value by $41,621.

b. A decrease in the amount of $3,398 for the change in fair market value from Fiscal 2024 year-end to the vesting date of 7,308 DSUs that were granted prior to Fiscal 2025 that vested during Fiscal 2025.

(5) In Fiscal 2024, the compensation actually paid to Mr. Reich was higher than the total amount disclosed in the Summary Compensation Table, due to the following:

a. An increase in the amount of $11,108 for the change in the stock's fair market value from Fiscal 2023 year-end to Fiscal 2024 year-end of awards granted prior to Fiscal 2024 that were outstanding and unvested as of Fiscal 2024 year-end, consisting of 47,908 outstanding and unvested DSUs that increased in fair market value by $11,108.

b. An increase in the amount of $2,663 for the change in fair market value from Fiscal 2023 year-end to the vesting date of awards granted prior to Fiscal 2024 that vested during Fiscal 2024, consisting of: (i) 5,742 DSUs that vested in Fiscal 2024 and decreased in value by $29; and (ii) 11,216 options to purchase shares of the Company's Class B Common Stock ("options") that vested in Fiscal 2024 and increased in value by $2,692.

(6) Michael Jonas, Executive Chairman, and Yi Tsai, Chief Financial Officer.

(7) In Fiscal 2026, average compensation actually paid to the non-PEO Named Executive Officers was less than the total amount disclosed in the Summary Compensation Table, due to the following:

a. A decrease in the amount of $41,448 for the change in fair market value from Fiscal 2025 year-end to Fiscal 2026 year-end of an award of 38,736 shares of Class B Common Stock granted to Michael Jonas prior to Fiscal 2026 that were outstanding and unvested as of Fiscal 2026 year-end.

b. A decrease in the amount of $44,354 for the average change in fair market value from Fiscal 2025 year-end to the vesting date of awards granted prior to Fiscal 2026 that vested during Fiscal 2026, consisting of: (i) 38,736 restricted shares of Class B Common Stock held by Michael Jonas that vested in Fiscal 2026 that decreased in fair market value by $37,225, based on the closing market price of one share of the Class B Common Stock on July 31, 2025, the last trading day in Fiscal 2025 ($4.02), and the closing market price of one share of the Class B Common Stock on February 9, 2026, the vesting date of the restricted shares ($3.059); and (ii) 2,000 DSUs held by Yi Tsai that vested in Fiscal 2026 and decreased in fair market value by $3,368 between the end of Fiscal 2025 and the vesting date.

(8) In Fiscal 2025, the average compensation actually paid to the non-PEO Named Executive Officers was higher than the total amount disclosed in the Summary Compensation Table, due to the following:

a. An increase in the amount of $30,989 for the fair market value of 77,472 shares of Class B Common Stock held by Michael Jonas that were outstanding and unvested as of Fiscal 2025 year-end, based on the closing market price of one share of the Class B Common Stock on July 31, 2025, the last day the stock was traded in Fiscal 2025 ($4.02).

20

b. An increase in the amount of $40,119 for the change in fair market value from Fiscal 2024 year-end to Fiscal 2025 year-end of awards granted prior to Fiscal 2025 that were outstanding and unvested as of Fiscal 2025 year-end, consisting of; (i) 33,000 outstanding and unvested DSUs held by Michael Jonas that increased in value by $27,247; and (ii) 6,000 outstanding and unvested DSUs held by Yi Tsai that increased in fair market value by $12,872.

c. A decrease in the amount of $33,164 for the average change in fair market value from Fiscal 2024 year-end to the vesting date of awards granted prior to Fiscal 2025 that vested during Fiscal 2025, consisting of: (i) 38,736 restricted shares of Class B Common Stock held by Michael Jonas that vested in Fiscal 2025 and decreased in fair market value by $30,059, based on the closing market price of one share of the Class B Common Stock on July 31, 2024, the last day that the stock was in Fiscal 2024 ($3.62), and the closing market price of one share the Class B Common Stock on February 7, 2025, the vesting date of the restricted shares ($2.844); (ii) 3,654 DSUs held by Michael Jonas that vested in Fiscal 2025 and decreased in fair market value by $1,699; and (iii) 3,024 DSUs held by Yi Tsai that vested in Fiscal 2025 and decreased in fair market value by $1,406.

(9) In Fiscal 2024, the average compensation actually paid to the non-PEO Named Executive Officers was higher than the total amount disclosed in the Summary Compensation Table, due to the following:

a. An increase in the amount of $420,673 for the fair market value of 116,208 shares of Class B Common Stock held by Michael Jonas that were outstanding and unvested as of Fiscal 2024 year-end, based on the closing market price of one share of the Class B Common Stock on July 31, 2024, the last day the stock was traded in Fiscal 2024 ($3.62).

b. An increase in the amount of $479 for the change in fair market value from Fiscal 2023 year-end to Fiscal 2024 year-end of awards granted prior to Fiscal 2024 that were outstanding and unvested as of Fiscal 2024 year-end, consisting of; (i) 23,954 outstanding and unvested DSUs held by Michael Jonas that increased in value by $5,554; and (ii) 19,824 outstanding and unvested DSUs held by Yi Tsai that decreased in fair market value by $4,596.

c. An increase in the amount of $17,862 for the average change in fair market value from Fiscal 2023 year-end to the vesting date of awards granted prior to Fiscal 2024 that vested during Fiscal 2024, consisting of: (i) 30,864 restricted shares of Class B Common Stock held by Michael Jonas that vested in Fiscal 2024 and increased in fair market value by $34,660, based on the closing market price of one share of the Class B Common Stock on July 31, 2023, the last day that the stock was in Fiscal 2023 ($2.10), and the closing market price of one share the Class B Common Stock on February 7, 2024, the vesting date of the restricted shares ($3.223); (ii) 2,871 DSUs held by Michael Jonas that vested in Fiscal 2024 and decreased in fair market value by $14; (iii) 2,376 DSUs held by Yi Tsai that vested in Fiscal 2024 and decreased in fair market value by $12; and (iv) 6,000 options held by Yi Tsai that vested in Fiscal 2024 and increased in fair market value by $1,090.

(10) Calculated based on a hypothetical $100 investment beginning at market close on July 31, 2023.

In Fiscal 2024, the relationship between compensation actually paid and the amounts awarded in the Summary Compensation Table was reversed for both our Chief Executive Officer and other Named Executive Officers in a fiscal year that saw a significant increase in Total Shareholder Return compared with Fiscal 2023 despite a net income (loss) that was greater than in Fiscal 2023. The increases in actual compensation were due to the increase in the value of unvested equity awards granted in prior periods, which explains the correlation with Total Shareholder Return.

In Fiscal 2025, compensation actually paid to our Chief Executive Officer and, on average, to the other Named Executive Officers exceeded the amounts reported in the Summary Compensation Table. This was driven primarily by the appreciation in the Company's stock price during Fiscal 2025, which increased the year-end value of unvested restricted stock and DSUs. In Fiscal 2025, the Company's net loss narrowed compared to the prior fiscal year, and, compensation actually paid moved directionally with Total Shareholder Return. However, the average compensation actually paid to our other (non-CEO) Named Executive Officers did not correlate to Total Shareholder Return over the same period. This is primarily attributable to Michael Jonas' compensation. He received his entire base salary for Fiscal Years 2020-2023 in the form of restricted shares granted in Fiscal 2020, and for Summary Compensation Table purposes, the full grant-date fair market value was recognized in the grant year (see footnote 5 to the Summary Compensation Table). Mr. Jonas received a grant in Fiscal 2024 representing his base salary for Fiscal Years 2024-2026 and, accordingly, did not receive such a grant in Fiscal 2025. As a result, the average compensation actually paid to the non-CEO Named Executive Officer group was lower because no new equity grant was made in Fiscal 2025, limiting year-over-year compensation actually paid despite the positive impact of stock-price appreciation.

In Fiscal 2026, compensation actually paid to our Chief Executive Officer and, on average, to our other Named Executive Officers was lower than the corresponding amounts reported in the Summary Compensation Table. The differences from Summary Compensation Table compensation reflected decreases in the fair value of previously granted equity awards that vested during Fiscal 2026 and, for the non-PEO Named Executive Officers, a decrease in the year-end fair value of Michael Jonas' unvested restricted shares and Yi Tsai's DSUs.

21

The year-over-year decreases in compensation actually paid were directionally consistent with the decrease in the value of a hypothetical $100 investment shown in the table from $191.43 at Fiscal 2025 year-end to $143.79 at Fiscal 2026 year-end, reflecting negative Total Shareholder Return during Fiscal 2026. In contrast, the Company's net loss narrowed from $2.392 million in Fiscal 2025 to $131,000 in Fiscal 2026. Thus, compensation actually paid declined despite the improvement in the Company's net results.

The cash component of our executive compensation is based on a number of factors, including, in the case of bonus compensation, goals for the Company and for individual executive officers that are set early in the fiscal year by the Compensation Committee of our Board of Directors. Those goals typically include specific financial metrics as well as other qualitative and quantitative factors related to operational and other matters. Following the end of each fiscal year, management reports to the Compensation Committee regarding actual performance relative to the goals, the contribution of each executive officer related to the goals set for the Company and the relevant executive and other factors regarding the performance of the executive officers and makes recommendations regarding various elements of compensation. The Compensation Committee then determines the compensation to be awarded.

Executive officers are also granted equity awards in securities of the Company from time to time to directly align their interests with those of the Company and its stockholders and its options and deferred stock units which may have performance-based vesting criteria in addition to time-based vesting criteria. Those vesting criteria may include metrics related to market capitalization or stock price which tend to further a positive correlation between compensation and Total Shareholder Return.

While all of the specific factors that drive compensation decisions may not directly correlate with our net income or Total Shareholder Return, many of the criteria used tend to impact compensation as well as Total Shareholder Return and that contributes to the correlation shown in the table above.

22

PROPOSALS REQUIRING YOUR VOTE

PROPOSAL NO. 1

ELECTION OF DIRECTORS

Pursuant to the Company's Certificate of Incorporation, the authorized number of members of the Board of Directors will be set by the Board of Directors from time to time. The Board of Directors has set the number of directors on the Board of Directors at six. There are currently six directors on the Board of Directors: Michael Jonas (Chairman of the Board and Executive Chairman of the Company), Howard S. Jonas (Vice Chairman of the Board), Mark Ghermezian, Elliot Gibber, Paul Packer and Gregory Suess. The current terms of all of the serving directors expire at the Annual Stockholders Meeting. All of the current directors are standing for re-election at the Annual Stockholders Meeting.

The nominees to the Board of Directors are Michael Jonas, Howard S. Jonas, Mark Ghermezian, Elliot Gibber, Paul Packer and Gregory Suess, each of whom has consented to be named in this Proxy Statement and to serve if elected. Each of the nominees is currently serving as a director of the Company. Brief biographical information about the nominees for directors is furnished below.

Each of these director nominees is standing for election for a term of one year until the 2028 annual meeting of stockholders, or until his successor is duly elected and qualified or until his earlier resignation or removal. A majority of the votes cast at the Annual Stockholders Meeting shall elect each director. Stockholders may not vote for more than six persons, which is the number of nominees identified herein. The following pages contain biographical information and other information about the nominees. Following each nominee's biographical information, we have provided information concerning particular experience, qualifications, attributes and/or skills that the Corporate Governance and Nominating Committee and the Board of Directors considered when determining that each nominee should serve as a director.

Michael Jonas has been our Executive Chairman since October 2017. He also served as Interim Chief Executive Officer from August 2019 until November 7, 2019. Michael Jonas has been the Chairman of our Board of Directors since November 14, 2016 and a member of our Board of Directors since May 23, 2016. He served as Executive Vice President of Genie Energy Ltd. from May 2014 until November 2018, as Director of Global Exploration and Business Development of Genie Energy from August 2014 until November 2018, and Chief Executive Officer of Genie Oil Development from May 2015 until November 2019. From November 2005 through December 2011, Michael Jonas served IDT Corporation in various positions such as analyst, vice president and manager of international business. Michael Jonas is a founding member of the Mongolian Oil Shale Association. Michael Jonas is our controlling stockholder, and the son of Howard S. Jonas, Vice-Chairman of our Board of Directors.

Key Attributes, Experience and Skills:

Michael Jonas has served as an executive officer of growing businesses and has managed development efforts for larger organizations. His experience in overseeing operations in growth mode will bring hands-on experience to the Board of Directors and guidance to management in executing the Company's growth plans.

Howard S. Jonas has been the Vice-Chairman of our Board of Directors since November 14, 2016. He was our Chairman of the Board from June 2, 2016 until November 14, 2016 and has been a member of our Board of Directors since May 23, 2016. Mr. Jonas founded IDT Corporation ("IDT") in August 1990 and has served as its Chairman of the Board of Directors since its inception. Howard S. Jonas served as Chief Executive Officer of IDT from October 2009 through December 2013 and from December 1991 until July 2001. Mr. Jonas is also the founder and has been President of Jonas Media Group (formerly Jonas Publishing) since its inception in 1979. From January 2014 until November 2017, Mr. Jonas served as the Chief Executive Officer of Genie Energy Ltd, a former subsidiary of IDT that was spun off to stockholders in October 2011; and has served as Chairman of the Board of Directors of Genie Energy since the spin-off. Howard S. Jonas also serves as the Chairman of the Board and, until April 2020, the Chief Executive Officer of IDW Media Holdings, Inc., a former subsidiary of IDT that was spun off to stockholders in September 2009. Mr. Jonas also has served as the Chairman of the Board of Rafael Holdings, Inc., a former subsidiary of IDT that was spun off to stockholders in March 2018 ("Rafael"), since its inception, and as Executive Chairman since June 13, 2022. From March 8, 2018 until April 30, 2021, he also served, and since June 1, 2025, he has served,

23

as Chief Executive Officer and President of Rafael. Mr. Jonas has been a director of Cornerstone Pharmaceuticals, Inc. since April 2013 and was appointed as its Chairman of the Board in April 2016. Howard S. Jonas received a B.A. in Economics from Harvard University.

Key Attributes, Experience and Skills:

As Chairman of the Board of each of IDT Corporation, Genie Energy, Rafael Holdings and IDW Media Holdings, Howard S. Jonas brings to the Board of Directors extensive and detailed knowledge of all aspects of the Company. He has extensive knowledge of the industry in which the Company operates. In addition, having Howard S. Jonas on the Board of Directors and as Vice-Chairman provides the Company with effective leadership.

Mark Ghermezian has served as a director since May 23, 2016. Mr. Ghermezian is a serial entrepreneur and successful investor with 20+ years of experience in founding, building, and investing in early-stage SaaS startups. Before becoming the Founder and General Partner at m]x[v Capital, Mr. Ghermezian co-founded Braze (Nasdaq: BRZE) and led the company as its founding CEO, pioneering a new category from ideation to IPO (Braze completed an initial public offering in November 2021). As an angel investor, Mr. Ghermezian was an early investor in companies such as Nutanix, Lattice, Thoughtspot, Rubrik, and Riskified, along with 50 other investments, largely focused on SaaS, experiencing several IPOs, unicorns, and successful exits. At m]x[v Capital, Mr. Ghermezian is proud to be a mentor to his founders and entrepreneurs, offering his experience and expertise to help their companies realize the same success.

Key Attributes, Experience and Skills:

Mr. Ghermezian is a well-recognized leader in the world of marketing automation and he brings to the Board of Directors extensive knowledge of the mobile apps eco-system. Besides his industry-specific experience, his work on the investment side, both as a fund manager and writer and speaker, will benefit the Company.

Elliot Gibber has served as a director since August 5, 2020 and was also a director from January 17, 2018 until November 7, 2019. Mr. Gibber served as the Interim Chief Executive Officer from November 7, 2019 to August 5, 2020. Mr. Gibber is President and Chief Executive Officer of Deb El Food Products, a significant company in the egg products business in the United States and worldwide. Mr. Gibber was also Chairman of the United Egg Association, keeping in constant communication with its membership and pushing initiatives that were good for the U.S. egg products industry. He has lent his egg product expertise to the American Egg Board as a Board Director and as a member of the Food Technology Advisory Council. Over the last ten years, Mr. Gibber has become an active investor in the real estate, high tech and medical technologies markets. Mr. Gibber is also actively involved in numerous non-profit organizations and serves on the Board of Trustees of the Orthodox Union, Yeshiva University, Rabbi Isaac Elchanan Theological Seminary (RIETS) and Albert Einstein College of Medicine. In 2008, Mr. Gibber was awarded an Honorary Doctorate degree from Yeshiva University.

Key Attributes, Experience and Skills:

Mr. Gibber has led his company towards significant expansion and has assisted many other companies in accelerating their growth. Drawing upon his wealth of experience, Mr. Gibber is well-equipped to assist in the ongoing development of the Company.

Paul Packer has served as a director since April 1, 2020. Mr. Packer founded Globis Capital Advisors LLC ("Globis"), an investment advisory, in 2001. Globis invests in startups, micro and small-cap companies with a focus on hi-tech. Mr. Packer was appointed and designated as Chairman of The United States Commission for the Preservation of America's Heritage Abroad by President Donald J. Trump in 2017 and reappointed to that position in 2019. Mr. Packer also serves as a director on the board of Elementor Ltd., a privately held company that offers an intuitive, front-end site builder for WordPress and had served as a director on the board of Wakingapp Ltd. prior to its sale to Scope AR in 2019. Mr. Packer previously served on the board of directors of Penguin Digital before it was acquired by Shutterfly.

Key Attributes, Experience and Skills:

Mr. Packer's significant experience as an investor and fund manager provides the Board with valuable insight into and perspectives on international financial, investment management and market matters. During his more than 20 years of experience with Globis, he has developed a deep understanding of capital structure, strategic planning, mergers and acquisitions and wide-ranging management expertise. Mr. Packer understands the concerns and interests of institutional investors and provides input to the Board of Directors and management from that perspective.

24

Gregory Suess has served as a director since August 5, 2020. Mr. Suess is a founding partner of Activist Artists Management, LLC ("Activist.co"), a full-service management and consulting company. Prior to Activist.co, Mr. Suess co-founded ROAR, which was one of Hollywood's leading entertainment management companies while under his leadership. Since February 2022, Mr. Suess has been a Senior Advisor at the law firm of Bradley Arant Boult Cummings LLP, and prior to that was with Glaser, Weil, Fink, Howard, Jordan & Shapiro for more than 24 years. Mr. Suess holds a Bachelor of Science from the University of Southern California (Lloyd Greif Center for Entrepreneurial Studies) and holds a JD/MBA from Pepperdine University.

Key Attributes, Experience and Skills:

Mr. Suess brings extensive state and federal legal expertise from his experience as a practicing attorney representing diverse clients. His business experience in the entertainment industry provides the Board of Directors with valuable perspectives on business opportunities in the entertainment industry as the Company seeks to expand beyond phone personalization.

The Board of Directors has no reason to believe that any of the persons named above will be unable or unwilling to serve as a director, if elected.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR
THE ELECTION OF THE NOMINEES NAMED ABOVE.

25

Executive Officers, Directors, Director Nominees and Named Executive Officers

The executive officers, directors, director nominees and Named Executive Officers of the Company are as follows:

Name

Age

Position

Morris Berger

68

Chief Executive Officer

Jonathan Reich

60

President, Chief Operating Officer and Named Executive Officer

Yi Tsai

70

Chief Financial Officer and Named Executive Officer

Michael Jonas

43

Executive Chairman, Chairman of the Board, Director, Director Nominee and Named Executive Officer

Howard S. Jonas

70

Vice-Chairman of the Board, Director and Director Nominee

Mark Ghermezian

44

Director and Director Nominee

Elliot Gibber

75

Director and Director Nominee

Paul Packer

55

Director and Director Nominee

Gregory Suess

54

Director and Director Nominee

Set forth below is biographical information with respect to the Company's current executive officers and Named Executive Officers, whose information is set forth above in Proposal No. 1:

Morris Berger has served as our Chief Executive Officer of the Company since October 1, 2026. Mr. Berger served as CEO of Zeno Media LLC, a global streaming audio and advertising technology company, for approximately 15 years. Earlier in his career, Mr. Berger served as CEO of Zedge (2005-2009), CEO of IDT Entertainment (2001-2005) and CMO of Net2Phone (1999-2001). He currently serves on the Board of Directors of Zeno Media and Mission Media. Mr. Berger received a B.A. from Bar Ilan University of Israel.

Jonathan Reich has served as our Chief Operating Officer since October 1, 2026 and as our President since July 12, 2011. Mr. Reich also served as our Chief Executive Officer from August 5, 2020 to September 30, 2026, Chief Operating Officer from July 12, 2011 to August 5, 2020 and as our Chief Financial Officer from March 7, 2016 to August 5, 2020. From 2007 to 2014, Mr. Reich served as President of Fabrix Systems, Inc. and, from 1999 to 2007, he served in various positions at Net2Phone, Inc., culminating with him serving as Chief Executive Officer of Net2Phone Global Services. Mr. Reich has been a director at the non-profit organization, Hand-in-Hand, since 2005. Mr. Reich received a B.S. and M.S. in Operations Research from Columbia University's School of Engineering and Applied Science in 1989 and 1993, respectively.

Yi Tsai has served as our Chief Financial Officer and Treasurer since August 5, 2020. Mr. Tsai served as our Controller from August 2017 to August 2020. Previously, Mr. Tsai served as Chief Financial Officer of Peerless Systems Corporation, a NASDAQ-listed company, from November 2012 until its sale to a financial buyer in February 2015. Mr. Tsai began his career in public accounting and held positions of increasing responsibility with various financial institutions and multinational corporations. Mr. Tsai is a CPA and holds a B.S. in Accounting from National Taipei University and an MBA in Finance from Case Western Reserve University's Weatherhead School of Management.

Relationships among Directors or Executive Officers

Howard S. Jonas and Michael Jonas are father and son. There are no other familial relationships among any of the directors or executive officers of the Company.

26

PROPOSAL NO. 2

APPROVAL OF THE COMPANY'S
2026 EQUITY INCENTIVE PLAN, AS AMENDED

The Company's stockholders are being asked to approve the Company's 2026 Equity Incentive Plan, which provides for the issuance of up to 438,695 shares of the Company's Class B Common Stock for the grant of awards thereunder, and an amendment thereto that will increase the number of shares of the Company's Class B Common Stock available for the grant of awards thereunder by 1,100,000 shares to a maximum of 1,538,695 shares (the 2026 Equity Incentive Plan, as amended, the "2026 Plan"). In addition, up to 582,857 shares underlying outstanding awards under the Company's 2016 Stock Option and Incentive Plan, as amended, may become available under the 2026 Plan if those awards terminate without share issuance, bringing the maximum number of shares available for grant under the 2026 Plan to 2,121,552 shares.

The Compensation Committee approved and recommended to the Board of Directors the proposed adoption of the 2026 Equity Incentive Plan on July 24, 2026, and the proposed amendment on September 8, 2026; and the Board of Directors adopted the proposed 2026 Equity Incentive Plan on July 24, 2026, and the proposed amendment on September 8, 2026, all subject to stockholder approval at the Annual Stockholders Meeting.

The amendment increasing the number of shares of Class B Common Stock available for the grant of awards under the Company's 2026 Equity Incentive Plan by 1,100,000 shares became necessary as a result of awards made or contemplated in September, 2026 providing for the issuance of 951,928 shares of the Company's Class B Common Stock, as follows: (i) the grant to Michael Jonas of stock options to purchase an aggregate of 386,244 shares of the Company's Class B Common Stock; (ii) the grant to Morris Berger of stock options to purchase an aggregate of 465,684 shares of the Company's Class B Common Stock; and (iii) the grant to Jonathan Reich of a combination of DSUs and restricted shares of stock that would constitute, in the aggregate, 100,000 shares of the Company's Class B Common Stock.

The Board of Directors believes that the approval of the 2026 Plan, including the amendment thereto increasing the number of shares of Class B Common Stock available for the grant of awards thereunder is necessary to attract and retain the services of key employees, directors and consultants of the Company essential to the Company's long-term success and to provide the Company with a sufficient reserve of shares of Class B Common Stock for grants thereunder.

The proposed adoption of the 2026 Equity Incentive Plan and the amendment thereto have been approved by the Compensation Committee and the Board of Directors, and are being submitted for a stockholder vote in order to enable the Company to grant, among other equity grants permitted pursuant to the 2026 Plan, options to purchase shares of Class B Common Stock which are incentive stock options ("ISOs") within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the "Code"); and because such approval may be required or advisable in connection with (i) the provisions set forth in Rule 16b-3 promulgated under the Exchange Act and (ii) the rules and regulations applicable to NYSE American-listed companies.

The following description of the 2026 Plan is a summary, does not purport to be complete and is qualified in its entirety by the full text of the 2026 Plan. A copy of the 2026 Plan is attached hereto as Exhibit A and has been filed with the SEC along with this Proxy Statement.

DESCRIPTION OF THE 2026 PLAN

The following is a summary of the material terms of the 2026 Plan. The summary does not purport to be complete and is qualified in its entirety by reference to the full text of the 2026 Plan, which is attached to this Proxy Statement as Exhibit A. Capitalized terms used but not defined in this summary have the meanings given to them in the 2026 Plan.

Background

The Company's 2016 Stock Option and Incentive Plan (the "2016 Plan") expired by its terms on May 23, 2026, and no further awards may be granted under the 2016 Plan. Awards outstanding under the 2016 Plan remain outstanding and continue to be governed by the terms of the 2016 Plan and the applicable award agreements. On July 24, 2026 (the "Effective Date"), the Board of Directors adopted the Zedge, Inc. 2026 Equity Incentive Plan, and

27

on September 8, 2026 the Board amended the 2026 Equity Incentive Plan to increase the number of shares authorized for issuance under it, in each case subject to stockholder approval. The Company is seeking stockholder approval of the 2026 Equity Incentive Plan, as amended (the "2026 Plan"), at the Annual Meeting.

Awards may be granted under the 2026 Equity Incentive Plan before stockholder approval, but the 2026 Equity Incentive Plan and all awards granted thereunder are conditioned on that approval. Until the 2026 Equity Incentive Plan is approved by the Company's stockholders, no option or stock appreciation right may be exercised, no restricted stock unit or other award may be settled, and no shares may be issued under the 2026 Equity Incentive Plan. If the stockholders do not approve the 2026 Equity Incentive Plan within twelve months after the Effective Date, the 2026 Equity Incentive Plan will terminate and all awards granted thereunder will be cancelled without consideration.

Purpose

The purposes of the 2026 Plan are to enable the Company and its affiliates to recruit and retain highly qualified employees, directors and consultants, to provide those persons with an incentive for productivity, and to provide them with an opportunity to share in the growth and value of the Company.

Shares Available for Awards

Subject to adjustment as described below, the maximum number of shares of Class B Common Stock that may be issued in respect of awards under the 2026 Plan is 2,121,552 shares, consisting of: (i) 288,695 shares that remained available for issuance under the 2016 Plan, and were not subject to outstanding awards, upon its expiration; plus (ii) 1,250,000 additional shares; plus (iii) up to 582,857 shares subject to awards outstanding under the 2016 Plan as of the Effective Date that thereafter expire, are cancelled or forfeited, are settled in cash or otherwise terminate without the issuance of shares. Shares in the last category become available only as, and to the extent that, those 2016 Plan awards terminate without the issuance of shares. No more than 100,000 shares may be issued pursuant to the exercise of incentive stock options ("ISOs") granted under the 2026 Plan. Shares issued under the 2026 Plan may be authorized but unissued shares or treasury shares.

Shares subject to an option or stock appreciation right that expires, terminates or is cancelled or forfeited without having been exercised in full, and shares subject to an award of restricted stock or restricted stock units that is cancelled or forfeited, will again become available for grant under the 2026 Plan. Shares withheld to satisfy tax withholding obligations, or in payment of the exercise price of an option, will also again become available for grant. Shares issued under awards granted in substitution for awards of an entity acquired by, or combined with, the Company or a subsidiary do not reduce the number of shares available under the 2026 Plan.

In the event of a merger, consolidation, reorganization, recapitalization, stock split, reverse stock split, spin-off, stock dividend, dividend in kind or similar corporate event or change in capital structure (other than ordinary cash dividends), the Compensation Committee will equitably adjust the number and kind of shares that may be issued under the 2026 Plan and under outstanding awards, the exercise, grant or purchase price of outstanding awards, and other affected terms, to prevent dilution or enlargement of participants' rights.

The market value of a share of Class B Common Stock as of November 17, 2026 was $2.60.

Administration

The 2026 Plan is administered by the Compensation Committee of the Board (or such other committee as the Board designates), and the Board may at any time exercise any of the Committee's rights and duties, other than matters that applicable law requires to be determined by the Committee. To the extent required by applicable law, the Committee will consist of at least two members, each of whom is a "non-employee director" within the meaning of Rule 16b-3 under the Exchange Act. The Committee has full authority to select award recipients, determine the type of award, determine the number of shares covered by each award, establish the other terms and conditions of each award, and modify or amend awards (subject to the participant's consent if the modification or amendment would materially impair the participant's rights). The Committee may also adopt, alter and repeal administrative rules, interpret the 2026 Plan and any award agreement, and correct defects, supply omissions and reconcile inconsistencies. The Committee's determinations are final, conclusive and binding. To the extent permitted by applicable law, the Committee may delegate to one or more officers of the Company the authority to grant awards to employees who are not executive officers subject to Section 16 of the Exchange Act.

28

Eligibility

Employees, directors, consultants and other service providers of the Company and its affiliates are eligible to receive awards under the 2026 Plan, provided they are eligible to receive securities registered on Form S-8 or exempt under Rule 701 under the Securities Act. Only employees of the Company or a parent or subsidiary corporation are eligible to receive ISOs. As of November 17, 2026, approximately 82 employees, four non-employee directors and approximately five to ten consultants were eligible to participate in the 2026 Plan.

Types of Awards

The 2026 Plan provides for the grant of stock options (ISOs and non-qualified stock options ("NQSOs")), stock appreciation rights ("SARs"), restricted stock, restricted stock units ("RSUs") and cash or other stock-based awards.

Stock Options. The exercise price of an option may not be less than 100% of the Fair Market Value of a share on the date of grant (110% in the case of an ISO granted to a holder of more than 10% of the total combined voting power of the Company's stock (a "Ten Percent Stockholder")), except that (i) options granted in substitution for options of an acquired or combined entity may have a lower exercise price to the extent permitted under Sections 424(a) and 409A of the Internal Revenue Code of 1986, as amended (the "Code"), and (ii) the Committee may grant an NQSO with an exercise price below Fair Market Value only if the Committee expressly determines at grant that the option is intended to be exempt from, or to comply with, Section 409A of the Code and the award agreement contains the exercise, payment and settlement terms necessary for that purpose. Under the 2026 Plan, "Fair Market Value" generally means the closing sales price of a share on the NYSE American (or other exchange on which the shares are listed) on the last preceding trading date.

The term of an option is fixed by the Committee but may not exceed 10 years (five years for an ISO granted to a Ten Percent Stockholder); unless the Committee provides otherwise, options have a 10-year term. Options vest and become exercisable at such times and subject to such conditions as the Committee determines, which may include continued service and the attainment of individual or corporate performance goals. The Committee may permit a participant to exercise the unvested portion of an option for restricted shares of stock subject to the same vesting terms. The exercise price may be paid by certified or bank check, by delivery of previously acquired shares, by "net settlement" (under which the participant receives shares having a value equal to the spread on the exercised portion of the option), or by other means the Committee accepts. To the extent the aggregate Fair Market Value (determined at grant) of shares with respect to which ISOs first become exercisable by a participant in any calendar year exceeds $100,000, the excess will be treated as NQSOs.

Stock Appreciation Rights. A SAR entitles the participant, upon exercise, to receive an amount equal to the excess of the Fair Market Value of a share on the date of exercise over the base price of the SAR, multiplied by the number of shares as to which the SAR is exercised, payable in cash, shares or a combination, as the Committee determines. The base price of a SAR may not be less than the Fair Market Value of a share on the date of grant, and the term of a SAR may not exceed 10 years.

Effect of Termination of Service on Options and SARs. Unless the award agreement or the Committee provides otherwise, the unvested portion of an option or SAR expires upon termination of service, and the vested portion remains exercisable (but not beyond the end of its term) for 12 months following termination due to death or disability and for 90 days following termination for any reason other than death, disability or cause. If a participant's service is terminated for cause, or the participant resigns at a time when grounds for a termination for cause existed, all unexercised options and SARs are forfeited immediately, as are any shares not yet delivered upon exercise (against a refund of any exercise price paid for those shares).

Restricted Stock. Restricted stock is an award of shares that are subject to forfeiture, and may not be sold, transferred, pledged or otherwise encumbered, during a restriction period determined by the Committee. The purchase price for restricted stock, if any, is determined by the Committee and may be zero. The lapse of restrictions may be conditioned on continued service, performance goals or other vesting conditions. During the restriction period, the participant may vote the shares. Any dividends or other distributions paid on restricted stock are subject to the same restriction period as the underlying shares (or, if the Committee so determines, reinvested in additional restricted stock), without interest. Unless the award agreement or the Committee provides otherwise, restricted stock that remains subject to forfeiture when the participant's service terminates is forfeited.

29

Restricted Stock Units. An RSU represents the right to receive, upon satisfaction of the applicable vesting conditions, an amount equal to the Fair Market Value of a share at the time of distribution, payable in cash, shares or a combination, as the Committee determines. A participant has no stockholder rights with respect to shares underlying an RSU until the shares are issued, although an award agreement may provide for dividend equivalents. Unless the award agreement or the Committee provides otherwise, unvested RSUs are forfeited upon termination of service.

Cash or Other Stock-Based Awards. The Committee may grant other awards payable in cash, shares or a combination, including awards of unrestricted shares and immediate cash payments, on such terms (including any performance goals and vesting conditions) as the Committee determines.

Change in Control

Awards under the 2026 Plan do not automatically vest upon a Change in Control. Instead, upon or in anticipation of a Change in Control, the Committee may, in its discretion and without participant consent, take one or more of the following actions, contingent on the Change in Control: (i) accelerate the vesting and exercisability of any or all awards, in whole or in part; (ii) cause options and SARs to become fully exercisable for a reasonable period before the Change in Control and cancel them, to the extent unexercised, at closing; (iii) cancel unvested awards, with or without consideration; (iv) cancel awards in exchange for substitute awards; (v) redeem restricted stock or RSUs for cash or other consideration equal to the Fair Market Value of an unrestricted share; (vi) cancel options and SARs in exchange for cash or other consideration equal to their spread (and cancel without payment any option or SAR having no spread); or (vii) take such other action as the Committee determines appropriate. Consideration paid upon cancellation of an award may be made subject to the vesting terms of the cancelled award or to the earn-out, escrow, holdback or similar terms applicable to stockholders in the transaction. Actions with respect to awards subject to Section 409A of the Code may be taken only to the extent consistent with Section 409A.

"Change in Control" generally means: (i) the acquisition by any person of beneficial ownership of securities representing 50% or more of the voting power for the election of directors, other than by the Company, a Company employee benefit plan, an entity owned by the Company's stockholders in substantially the same proportions as their ownership of the Company, or a Permitted Holder; (ii) a change in a majority of the Board during any twelve-month period, other than through directors approved by the incumbent directors; (iii) a merger or consolidation after which the Company's pre-transaction stockholders do not own 50% or more of the voting power of the surviving entity; (iv) a sale or other disposition of all or substantially all of the Company's assets; (v) a liquidation or dissolution of the Company; or (vi) any other event the Board deems to constitute a Change in Control. "Permitted Holders" are Michael Jonas, his family members, trusts solely for the benefit of any of them, entities controlled by any of them, and any group consisting solely of any of them, and no Change in Control occurs solely as a result of transfers of securities among, or acquisitions of securities by, Permitted Holders. For awards subject to Section 409A of the Code, an event is a Change in Control only if it is also a "change in control event" under Section 409A, to the extent necessary to comply with Section 409A.

Annual Limit on Non-Employee Director Compensation

Beginning with the first fiscal year following the year in which the stockholders approve the 2026 Plan, the aggregate cash and equity compensation payable to a non-employee director for service as a non-employee director with respect to a fiscal year, whether under the 2026 Plan or otherwise, may not exceed $750,000 ($1,000,000 for the fiscal year in which the director is first elected or appointed). Equity awards are counted at their grant-date fair value for financial reporting purposes. The limit does not apply to compensation for service as chairperson of the Board or lead independent director, compensation for services in another capacity (such as an advisor or consultant), or compensation awarded by the Board in extraordinary circumstances, in each case provided that the recipient director does not participate in the decision to award it. The 2026 Plan does not provide for automatic annual grants to non-employee directors.

30

Repricing

The Committee may reprice options and SARs without stockholder approval, including by cancelling outstanding options or SARs and granting replacement awards with a lower exercise or base price, by cancelling underwater options or SARs in exchange for cash or other equity securities of the Company, by directly or indirectly reducing the exercise or base price of outstanding options or SARs, or by any other method.

Transferability

Awards generally may not be pledged, encumbered or transferred other than by will or the laws of descent and distribution, and are exercisable during the participant's lifetime only by the participant or the participant's guardian or legal representative. The Committee may permit awards (other than ISOs) to be transferred without consideration to immediate family members, trusts for their benefit, partnerships in which they are the only partners, other similar estate planning vehicles, or other transferees the Committee permits. Participants may designate beneficiaries in the manner established by the Committee.

Company Policies; Clawback; Restrictive Covenants

Awards and the shares subject to them are subject to the Company's stock ownership, securities trading, anti-hedging and similar policies as in effect from time to time. Awards, whether vested or unvested, are subject to rescission, cancellation, forfeiture, recoupment or other recovery under any clawback or similar policy of the Company applicable to the participant, any applicable award agreement, and any law, regulation or stock exchange listing requirement. The Committee may also condition a participant's right to receive, vest in, retain or realize any benefit from an award on compliance with non-competition, non-solicitation, confidentiality, non-disparagement and other restrictive covenants, and may provide in an award agreement that a participant who breaches such covenants, or who voluntarily terminates service and then competes with the Company, will forfeit outstanding awards and repay gains realized from awards during a specified period.

Tax Withholding

Participants must pay, or make arrangements satisfactory to the Company for the payment of, all taxes required to be withheld in connection with an award. To the extent authorized by the Committee, withholding obligations may be satisfied by withholding shares otherwise deliverable under the award, up to the amount determined using the maximum statutory tax rate in the applicable jurisdiction.

Section 409A

The 2026 Plan and each award are intended to be exempt from or to comply with Section 409A of the Code and are to be interpreted and administered accordingly. Neither the Company nor any affiliate guarantees any particular tax treatment or will have any liability to a participant if an award fails to be exempt from or to comply with Section 409A.

Awards to Non-U.S. Participants

To comply with the laws of countries other than the United States in which the Company and its subsidiaries operate or have service providers, the Committee may modify the terms of awards granted to individuals outside the United States, establish subplans and modified procedures, and take other actions to obtain or comply with local regulatory approvals or exemptions, but may not increase the share limits of the 2026 Plan.

Amendment and Termination

The Board may amend or terminate the 2026 Plan at any time, subject to any stockholder approval required by applicable law or stock exchange rules. Unless extended with stockholder approval, the 2026 Plan will terminate on July 24, 2036, the tenth anniversary of the Effective Date, and no awards may be granted thereafter. Awards outstanding when the 2026 Plan terminates will remain outstanding in accordance with their terms.

31

New Plan Benefits

Two option grants have been made under the 2026 Plan, in each case subject to stockholder approval of the 2026 Equity Incentive Plan and the amendment thereto adding additional shares available for grant thereunder. On September 10, 2026, Michael Jonas, Executive Chairman, was granted non-qualified stock options to purchase 386,244 shares of Class B Common Stock at an exercise price of $2.93 per share, vesting ratably in three annual installments on September 9, 2027, September 8, 2028 and September 7, 2029, subject to his continued service. On October 28, 2026, Morris Berger, Chief Executive Officer, was granted non-qualified stock options to purchase 465,684 shares of Class B Common Stock at an exercise price of $2.56 per share, vesting in twenty equal quarterly installments over five years measured from October 1, 2026, subject to his continued service, with no installment vesting before stockholder approval of the 2026 Equity Incentive Plan and the amendment thereto. Each option has a ten-year term, was granted at an exercise price equal to the Fair Market Value of a share of Class B Common Stock on the date of grant, and may not be exercised unless and until stockholder approval of the 2026 Equity Incentive Plan and the amendment thereto is obtained. In addition, as described elsewhere in this Proxy Statement, the Company has agreed to grant, and contemplates granting, to Jonathan Reich, Chief Operating Officer and President, restricted shares of stock and deferred stock units constituting, in the aggregate, 100,000 shares of Class B Common Stock, which grant is expected to be made following stockholder approval of the 2026 Equity Incentive Plan and the amendment thereto. The following table reflects those option grants and the contemplated awards to Mr. Reich. All other awards under the 2026 Plan will be made at the discretion of the Committee and, accordingly, are not currently determinable.

Name and Position

Dollar Value
($)
(1)

Number of
Shares Subject
to Awards

Michael Jonas, Executive Chairman

-

386,244

Morris Berger, Chief Executive Officer

-

465,684

Jonathan Reich, Chief Operating Officer and President

Not determinable

100,000

​(2)

Yi Tsai, Chief Financial Officer

-

0

All current executive officers as a group

Not determinable

951,928

​(2)

All current directors who are not executive officers as a group

-

0

All employees, including all current officers who are not executive officers,
as a group

-

0

____________

(1) In accordance with SEC staff guidance, no dollar value is presented for the stock options. The dollar value of the restricted stock and deferred stock unit awards expected to be granted to Mr. Reich is not currently determinable.

(2) Includes 100,000 shares of Class B Common Stock subject to the Company's obligation to grant restricted stock and deferred stock units to Mr. Reich following stockholder approval of the 2026 Plan and the amendment. The awards have not yet been granted.

Interests of Directors and Executive Officers

The Company's directors and executive officers are eligible to receive awards under the 2026 Plan. Michael Jonas and Morris Berger have received option grants subject to stockholder approval of the 2026 Equity Incentive Plan and the amendment thereto, and Jonathan Reich is expected to receive awards following that approval, in each case as described above under "New Plan Benefits." Accordingly, they have an interest in this proposal.

32

FEDERAL INCOME TAX CONSEQUENCES OF AWARDS UNDER THE 2026 PLAN

The following is a general summary, based on current law, of the principal U.S. federal income tax consequences to participants and the Company of awards under the 2026 Plan. It is not a complete description of all applicable tax rules, does not address state, local or non-U.S. taxes or the circumstances of any particular participant, and is not intended as tax advice to any participant. Tax laws are subject to change. Participants should consult their own tax advisors.

Incentive Stock Options. A participant does not recognize taxable income upon the grant of an ISO, and generally does not recognize regular taxable income upon its exercise if the participant has been an employee of the Company (or a parent or subsidiary corporation) at all times from the date of grant until three months before the date of exercise (one year in the case of termination due to permanent and total disability; the employment requirement does not apply to an exercise following the participant's death). However, the excess of the fair market value of the shares at exercise over the exercise price is an adjustment for purposes of the alternative minimum tax, which may result in alternative minimum tax liability in the year of exercise. If an ISO is exercised after the applicable post-employment period, it is taxed as an NQSO.

If the participant holds the shares acquired on exercise of an ISO for at least two years from the date of grant and one year from the date of exercise (the "ISO holding period"), any gain or loss on a subsequent sale will be long-term capital gain or loss, and the Company will not be entitled to a deduction. If the participant disposes of the shares before the end of the ISO holding period (a "disqualifying disposition"), the participant will generally recognize ordinary income in the year of disposition equal to the lesser of (i) the excess of the fair market value of the shares on the date of exercise over the exercise price and (ii) the excess of the amount realized on the disposition over the exercise price, and any further gain will be capital gain (long-term or short-term depending on how long the shares were held). Ordinary income from a disqualifying disposition is not subject to income tax withholding or employment taxes. The Company generally will be entitled to a deduction equal to the ordinary income recognized by the participant on a disqualifying disposition.

If a participant pays the exercise price of an ISO with shares previously acquired upon exercise of an ISO before the ISO holding period for those shares has been met, the delivery of those shares is a disqualifying disposition of them.

Non-Qualified Stock Options. A participant generally does not recognize taxable income upon the grant of an NQSO because such options generally do not have a readily ascertainable fair market value at grant. Upon exercise, the participant recognizes ordinary income equal to the excess of the fair market value of the shares acquired on the date of exercise over the exercise price. For employees, this income is subject to income tax withholding and employment taxes. The participant's tax basis in the shares will equal their fair market value on the date of exercise, and any subsequent gain or loss on disposition of the shares will be capital gain or loss. The Company generally will be entitled to a deduction equal to the ordinary income recognized by the participant. If a participant pays the exercise price with previously owned shares (other than shares whose delivery is a disqualifying disposition of ISO shares), the participant generally will not recognize gain or loss on the shares delivered.

Stock Appreciation Rights. A participant does not recognize taxable income upon the grant of a SAR. Upon exercise, the participant recognizes ordinary income equal to the cash and the fair market value of any shares received, and the Company generally will be entitled to a corresponding deduction.

Restricted Stock. A participant who receives restricted stock that is nontransferable and subject to a substantial risk of forfeiture generally does not recognize taxable income at grant. Instead, the participant recognizes ordinary income when the shares vest, equal to the excess of the fair market value of the shares on the vesting date over the amount, if any, paid for them. Alternatively, the participant may make an election under Section 83(b) of the Code, within 30 days after the shares are transferred, to recognize ordinary income at the time of transfer equal to the excess of the fair market value of the shares at that time over the amount, if any, paid for them. If a Section 83(b) election is made, the participant will not recognize additional income when the shares vest, but if the shares are later forfeited the participant generally may not deduct the income previously recognized. Dividends paid on restricted stock for which no Section 83(b) election was made are taxed as compensation income when paid to the participant. The same rules apply to restricted stock acquired upon the early exercise of an unvested option. The Company generally will be entitled to a deduction equal to the ordinary income recognized by the participant, at the time it is recognized.

33

Restricted Stock Units. A participant does not recognize taxable income upon the grant of an RSU, and a Section 83(b) election is not available for RSUs. The participant recognizes ordinary income when the RSU is settled, equal to the cash and the fair market value of any shares received, and the Company generally will be entitled to a corresponding deduction. For employees, Social Security and Medicare taxes may apply when the RSU vests, which can be earlier than settlement. Dividend equivalents, if any, are taxed as ordinary income when paid.

Cash or Other Stock-Based Awards. A participant generally recognizes ordinary income upon receipt of cash or unrestricted shares under a cash or other stock-based award, equal to the cash and the fair market value of the shares received, and the Company generally will be entitled to a corresponding deduction. Awards of shares that are subject to vesting are taxed under the rules described above for restricted stock.

Withholding and Deductibility Generally. Ordinary income recognized by employees in connection with awards (other than ISOs, as described above) is compensation subject to income tax withholding and employment taxes. Ordinary income recognized by non-employee directors and consultants is generally subject to self-employment tax rather than withholding. The Company's deduction in each case is subject to the requirement that the compensation be reasonable and an ordinary and necessary business expense, and to the limitations of Sections 162(m) and 280G of the Code described below.

Section 409A. Section 409A of the Code imposes requirements on nonqualified deferred compensation, including restrictions on the timing of deferral elections and payments. Options and SARs granted with an exercise or base price not less than the fair market value of the underlying shares on the date of grant and without any additional deferral feature, restricted stock, and RSUs and other awards that are settled shortly after vesting are generally exempt from Section 409A. Nonqualified stock options granted with an exercise price below fair market value, or containing an additional deferral feature, generally are subject to Section 409A unless structured to qualify for an exemption, such as the short-term deferral exemption, or to comply with its requirements. RSUs and other awards with deferred settlement may be subject to Section 409A and are intended to comply with it. If an award subject to Section 409A fails to comply, the participant may be required to include the deferred amounts in income when they vest and may be subject to an additional 20% tax and interest.

Section 162(m). Section 162(m) of the Code generally limits to $1 million per year the deduction a publicly held corporation may take for compensation paid to a "covered employee," which includes the chief executive officer, the chief financial officer, the three other most highly compensated executive officers, and any individual who was a covered employee for any taxable year beginning after December 31, 2016. Beginning with taxable years beginning after December 31, 2025, the limit applies to compensation paid by all members of the Company's controlled group, and beginning with taxable years beginning after December 31, 2026, covered employees also include the five most highly compensated employees not otherwise covered. There is no exception for performance-based compensation. Accordingly, compensation attributable to awards under the 2026 Plan, when combined with other compensation, may not be fully deductible. The Committee may grant awards that are not deductible when it considers it appropriate to do so.

Section 280G. If the vesting or payment of awards is accelerated or enhanced in connection with a change in control of the Company, all or part of the value of the awards may be treated as "excess parachute payments" under Section 280G of the Code, in which case the Company would not be entitled to a deduction for those payments and the participant would be subject to a 20% excise tax on them under Section 4999 of the Code.

Non-U.S. Participants. Participants who are subject to tax outside the United States may be subject to different or additional tax consequences, which are not described in this summary.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR APPROVAL
OF THE COMPANY'S 2026 EQUITY INCENTIVE PLAN, AS AMENDED

34

PROPOSAL NO. 3

APPROVAL OF THE ISSUANCE OF THE CLASS B COMMON STOCK WARRANTS ISSUED IN THE
SEPTEMBER 2026 PRIVATE PLACEMENT AND THE SHARES OF CLASS B COMMON STOCK
ISSUABLE UPON THEIR EXERCISE

Overview

The Company's stockholders are being asked to approve the issuance of the Class B Common Stock Purchase Warrants issued in the Company's September 2026 private placement (the "September Placement") and the issuance of up to 2,354,803 shares of the Company's Class B Common Stock upon exercise of such Warrants.

The September 2026 Private Placement

In September 2026, the Company entered into a Securities Purchase Agreement (the "Purchase Agreement") for the sale of an aggregate of 2,616,447 shares of Class B Common Stock (the "Placement Shares") and warrants (the "Warrants") to purchase 2,354,803 shares of the Company's Class B Common Stock (the "Warrant Shares"), with Howard S. Jonas, the Company's Vice Chairman and father of Michael Jonas, our Executive Chairman and Chairman of the Board (and the holder of a controlling interest of our outstanding common stock), Elliot Gibber, a member of the Company's Board of Directors, and a third investor. Mr. Jonas assigned his rights and obligations under the Purchase Agreement to Chartwell Holding LLC ("Chartwell"). Howard S. Jonas is deemed to beneficially own the securities held by Chartwell.

The Company completed the September Placement with Chartwell, Mr. Gibber and the third investor (collectively, the "Purchasers"), for aggregate gross proceeds of $7,675,000.

The purchase price per Placement Share was equal to the closing price of the Class B Common Stock on the NYSE American on the trading day immediately preceding the date on which the applicable Purchaser executed the Purchase Agreement ($2.93 per Placement Share for Chartwell and Mr. Gibber; and $2.98 per Placement Share for the third investor). The Purchasers paid no separate additional consideration for the Warrants.

The Company intends to use the net proceeds of the private placement and any proceeds from exercise of the Warrants to accelerate the growth of DataSeeds.AI and for working capital and general corporate purposes.

Material Terms of the Warrants

Exercise price and payment. The exercise price per Warrant Share is equal to 110% of the applicable Purchaser's purchase price per Placement Share ($3.22 per Warrant Share for Chartwell and Mr. Gibber; and $3.28 per Warrant Share for the third investor), in each case subject to adjustment as provided in the Warrants. The Warrants require payment of the exercise price in cash and do not permit cashless exercise.

Exercise period. Each Warrant becomes exercisable on the date (the "Initial Exercise Date") which is the later of: (i) the date which is six months after the closing of the applicable Purchaser's purchase; and (ii) the date on which the approval of the Company's stockholders under applicable NYSE American rules for the issuance of the Warrants and the Warrant Shares is obtained ("Stockholder Approval"). Each Warrant expires on the fifth anniversary of its Initial Exercise Date.

Adjustments. The exercise price and number of Warrant Shares are subject to proportionate adjustment for stock dividends, stock splits, combinations and reclassifications. The Warrants also provide for appropriate good faith adjustments to the exercise price by the Board of Directors for certain other events to protect the holder against dilution. With the holder's prior written consent, the Company may reduce the then-current exercise price to any amount, and for any period of time, that the Board of Directors deems appropriate. The Warrants do not contain price-based anti-dilution protection.

Fundamental transactions. Following a merger, disposition of all or substantially all assets or other fundamental transaction specified in the Warrants, holders are entitled, upon exercise, to the securities or other consideration they would have received if they had exercised immediately before the transaction, subject to the terms of the Warrants.

35

Transfer restrictions and stockholder rights. The Warrants may not be sold, transferred or assigned. The Company has no contractual obligation to register the Warrants or the Warrant Shares for resale under the Securities Act of 1933 or any state securities laws, or list the Warrants on any exchange or register them under the Securities Exchange Act of 1934. The Warrant Shares will be "restricted securities" and may be resold only pursuant to registration under the Securities Act of 1933, as amended, or an available exemption, such as Rule 144. The Warrants confer no voting, dividend or other stockholder rights before exercise. The Warrant Shares, when issued, will have the same rights as other outstanding shares of Class B Common Stock.

This summary is qualified in its entirety by the Purchase Agreement and the form of Warrant filed as Exhibits 10.1 and 4.1, respectively, to the Company's Current Report on Form 8-K filed on September 10, 2026.

Reasons for Seeking Stockholder Approval

The Class B Common Stock is listed on the NYSE American. Section 713(a) of the Company Guide generally requires stockholder approval for a non-public transaction involving the sale, issuance or potential issuance of common stock, or securities convertible into or exercisable for common stock, equal to 20% or more of the pre-transaction outstanding common stock at a price below the applicable "Minimum Price". The Minimum Price is the lower of the official closing price immediately preceding the signing of the binding agreement and the average official closing price for the five trading days immediately preceding signing.

Each Purchaser's price per Placement Share equaled the applicable preceding closing price, and the Placement Shares represented less than 20% of the pre-transaction outstanding shares of Class B Common Stock. The Warrants have exercise prices equal to 110% of the applicable purchase price per Placement Share and may not be exercised until at least six months after the applicable closing. However, the Purchasers paid no separate additional consideration for the Warrants. If a value were to be attributed to the Warrants, the Warrants could be deemed to have been issued at a price below the applicable Minimum Price. Accordingly, the Company is seeking approval of the Warrants and the Warrant Shares for purposes of Section 713(a), to the extent applicable.

Section 711 of the Company Guide requires stockholder approval of equity compensation arrangements under which officers, directors, employees or consultants may acquire options or shares of stock, subject to specified exceptions. Securities issued to directors in a private financing may be treated as equity compensation if issued below the applicable market value. Since Howard S. Jonas and Mr. Gibber are directors and received the accompanying Warrants for no separate additional consideration, even though the Warrants were issued as part of the September Placement and not as compensation for their service on the Board or otherwise to the Company, the Company is also seeking approval under Section 711 of the Warrants issued to Chartwell and Mr. Gibber and the Warrant Shares issuable upon their exercise.

In addition, Stockholder Approval of the issuance of the Warrants and Warrant Shares is an express condition to exercise under the transaction documents. The Company agreed to use reasonable best efforts to submit this Proposal at its next annual or special meeting of stockholders and to solicit proxies in the same manner as for its other management proposals.

The Company does not believe that the exercise of the Warrants would result in a change of control of the Company for purposes of Section 713(b) of the Company Guide, because Michael Jonas holds, and following the exercise of all of the Warrants would continue to hold, a majority of the combined voting power of the Company's outstanding capital stock.

Effects of Approval and Non-approval

If this Proposal is approved, the stockholder approval condition to exercise will be satisfied. Upon expiration of the applicable six-month period, the Purchasers would be permitted to exercise their Warrants in accordance with their terms. Full cash exercise at the current exercise prices would result in the issuance of 2,354,803 additional shares of Class B Common Stock and gross proceeds to the Company of approximately $7.59 million. There can be no assurance that any Warrants will be exercised.

Issuance of the Warrant Shares upon exercise would reduce the percentage ownership and voting power of other stockholders and could dilute book value and future earnings per share. For illustration, based on the 524,775 shares of Class A Common Stock and 14,998,014 shares of Class B Common Stock outstanding on November 17, 2026, and

36

assuming there are no other changes in the number of outstanding shares, full exercise of the Warrants would increase the number of shares of Class B Common Stock outstanding by approximately 15.7%, and the Warrant Shares would represent approximately 13.6% of the shares of Class B Common Stock outstanding after exercise and approximately 7.1% of the combined voting power after exercise.

Assuming the exercise in full of Chartwell's Warrants and there are no other changes in number of the outstanding shares, Howard S. Jonas would beneficially own 4,341,392 shares of Class B Common Stock, or approximately 25.5% of the outstanding Class B Common Stock and approximately 13.3% of the combined voting power.

Assuming the exercise in full of Mr. Gibber's Warrants and there are no other change in the number of outstanding shares, Mr. Gibber would beneficially own 691,611 shares of Class B Common Stock, or approximately 4.5% of the outstanding Class B Common Stock and approximately 2.1% of the combined voting power.

Sales of Warrant Shares, or the perception that such sales may occur, could adversely affect the market price of the Class B Common Stock.

If this Proposal is not approved, the Warrants will remain unexercisable and the Company will not receive exercise proceeds unless Stockholder Approval is subsequently obtained. Non-approval will not reverse the completed September Placement, cancel the issuance of the Placement Shares or require the return of the proceeds already received.

Interests of Certain Persons

Howard S. Jonas has an interest in this proposal through Chartwell's Warrants to purchase 1,996,587 Warrant Shares. Howard S. Jonas is deemed to beneficially own the securities held by Chartwell.

Elliot Gibber has an interest in this proposal through his Warrants to purchase 199,659 Warrant Shares.

Those interests differ from the interests of stockholders generally. Michael Jonas, the Company's Executive Chairman, Chairman of the Board of Directors and controlling stockholder, is Howard S. Jonas's son. The September Placement was reviewed and approved as a Related Person Transaction by the Corporate Governance and Nominating Committee, with Mr. Gibber not participating, and was approved by the Board of Directors, with Howard S. Jonas, Michael Jonas and Mr. Gibber abstaining.

Voting Restrictions and Vote Required

Under the Purchase Agreement, each Purchaser agreed not to vote any shares of Class B Common Stock held by that Purchaser as of the Record Date on this Proposal. The Warrants contain a corresponding covenant by each holder. This restriction applies to all such shares held by a Purchaser, including shares acquired before the September Placement, and not only to the Placement Shares. Michael Jonas, who holds approximately 56.2% of the combined voting power of the Company's outstanding capital stock, is not a Purchaser and is not subject to this restriction.

Approval requires the affirmative vote of a majority of the voting power of the shares voted on this Proposal at the Annual Stockholders Meeting. The Class A Common Stock and Class B Common Stock vote together as a single class, with three votes per Class A share and one-tenth of one vote per Class B share. Abstentions and broker non-votes will not count as votes cast and will have no effect on the outcome. This is a non-routine proposal, and brokers do not have discretionary authority to vote on this proposal without instructions from the beneficial owner.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" APPROVAL OF THE ISSUANCE OF THE CLASS B COMMON STOCK WARRANTS ISSUED IN THE SEPTEMBER 2026 PRIVATE PLACEMENT AND THE SHARES OF CLASS B COMMON STOCK ISSUABLE UPON THEIR EXERCISE

37

PROPOSAL NO. 4

RATIFICATION OF THE APPOINTMENT OF UHY LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
FOR THE FISCAL YEAR ENDING JULY 31, 2027

The Company's stockholders are being asked to ratify the Board of Directors' appointment of UHY LLP as the Company's independent registered public accounting firm for the fiscal year ending July 31, 2027.

UHY is the Company's current independent registered public accounting firm and has served the Company as its independent registered public accounting firm since February 7, 2023. UHY was the Company's independent registered public accounting firm for Fiscal 2026. The Audit Committee of the Board of Directors has appointed UHY as the Company's independent registered public accounting firm for Fiscal 2027.

Neither the Company's governing documents nor applicable law require stockholder ratification of our independent registered public accounting firm. However, the Audit Committee will consider the results of the stockholder vote for this proposal and, in the event of a negative vote, will review any future selection of UHY. Even if UHY's appointment is ratified by the stockholders, the Audit Committee may, in its discretion, appoint a new independent registered public accounting firm at any time if it determines that such a change would be in the best interests of the Company and its stockholders.

We expect that representatives for UHY will be present by phone at the Annual Meeting, will be available to respond to appropriate questions and will have the opportunity to make such statements as they may desire.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR
THE RATIFICATION OF THE APPOINTMENT OF UHY
AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
FOR THE FISCAL YEAR ENDING JULY 31, 2027.

38

EQUITY COMPENSATION PLAN INFORMATION

Employee Stock Incentive Program

The Company adopted the 2016 Plan and the 2026 Plan (subject to stockholder approval), pursuant to which, among other things, options to purchase shares of Class B Common Stock and restricted shares of Class B Common Stock may be awarded.

Equity Compensation Plans and Individual Compensation Arrangements

The following chart provides aggregate information regarding grants under all equity compensation plans of the Company as of July 31, 2026.

Plan Category

Number of
Securities to
be Issued
upon Exercise
of Outstanding
Options
(1)

Weighted-
Average
Exercise
Price of
Outstanding
Options

Number of
Securities
Remaining
Available for
Future
Issuance
under Equity
Compensation
Plans

Equity compensation plans approved by security holders

530,000

$

2.21

289,000

Equity compensation plans not approved by security holders

-

-

438,695

​(2)

Total

530,000

$

2.21

727,695

____________

(1) Reflects all outstanding options for shares of Class B Common Stock as of July 31, 2026. Does not include shares of Class B Common Stock issuable pursuant to 25,401 outstanding DSUs that will be deducted from the 2016 Plan when the underlying shares of Class B Common Stock are issued on the DSUs' vesting dates. The number of shares of Class B Common Stock to be issued on the DSUs' vesting date will vary depending upon the market price of the Class B Common Stock. Please see Note 12 - Stock-Based Compensation to our Consolidated Financial Statements included in the Form 10-K for the Fiscal Year ended July 31, 2026.

(2) Reflects 438,695 shares available under the Company's 2026 Equity Incentive Plan (prior to amendment), which are subject to stockholder approval (see Proposal No. 2).

39

THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

UHY LLP is the Company's independent registered public accounting firm and has served the Company as its independent registered public accounting firm since February 7, 2023. The Audit Committee may, in its discretion, appoint a new independent registered public accounting firm at any time if it determines that such a change would be in the best interests of the Company and its stockholders.

We expect that representatives for UHY will be present at the Annual Stockholders Meeting, will be available to respond to appropriate questions and will have the opportunity to make such statements as they may desire.

Audit and Non-Audit Fees

The following table presents fees billed for professional services rendered for Fiscal 2026 and Fiscal 2025.

Fiscal Year Ended July 31

2026

2025

Audit Fees(1)

$

337,875

$

348,125

Audit-Related Fees

Tax Fees

All Other Fees

Total

$

337,875

$

348,125

____________

(1) Audit Fees consist of fees for the audit of the Company's financial statements included in the Company's Form 10-K, reviews of financial statements included in the Company's Form 10-Qs, fees related to administration fees, and a statutory audit fee for GuruShots for the audit performed by a UHY affiliate located in Israel.

Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of the Independent Registered Public Accounting Firm

The Audit Committee is responsible for appointing, setting compensation for, and overseeing the work of the Company's independent registered public accounting firm. The Audit Committee has established a policy regarding pre-approval of all audit and permissible non-audit services provided by the independent registered public accounting firm, and all such services were approved by the Audit Committee.

The Audit Committee assesses requests for services by the independent registered public accounting firm using several factors. The Audit Committee will consider whether such services are consistent with the rules of the Public Company Accounting Oversight Board (PCAOB) and SEC on auditor independence. In addition, the Audit Committee will determine whether the independent registered public accounting firm is best positioned to provide the most effective and efficient service based upon the members' familiarity with the Company's business, people, culture, accounting systems, risk profile and whether the service might enhance the Company's ability to manage or control risk or improve audit quality.

Report of the Audit Committee

The primary purpose of the Audit Committee is to assist the Board of Directors in its general oversight of the Company's financial reporting process, internal controls, and audit functions. The Audit Committee's function is more fully described in its charter, which can be found in the Corporate Governance section of the Company's web site, http://investor.zedge.net/ZDGE/corporate_governance. The Audit Committee reviews its charter on a no less than annual basis. The Board of Directors, with input from its Corporate Governance and Nominating Committee, annually reviews the NYSE American listing standards' definition of independence for Audit Committee members, questionnaires completed by the Audit Committee members/nominees, and all information available to the Board of Directors and Corporate Governance and Nominating Committee regarding relationships that could reasonably be expected to impact independence in accordance with those standards. At meetings held on October 26, 2026, the Corporate Governance and Nominating Committee determined and recommended to the Board of Directors that it determine, and based in part on that recommendation, the Board of Directors determined that each member of the Audit Committee meets the relevant standards. In addition, the Corporate Governance and Nominating Committee annually reviews the definitions of financial literacy under the relevant portion of the NYSE American listing standards, and of audit committee financial expert under SEC rules, with the information provided in the completed questionnaires to make determinations and recommendations to the Board of Directors. The Board of Directors, with

40

input from its Corporate Governance and Nominating Committee, has also determined that each of Gregory Suess, Elliot Gibber and Paul Packer is financially literate in accordance with the NYSE American listing standards and that Gregory Suess qualifies as an "audit committee financial expert within the meaning of Item 407(d)(5) of Regulation S-K.

The Company's management is responsible for the preparation, presentation, and integrity of the Company's financial statements, accounting and financial reporting principles, internal controls, and procedures designed to ensure compliance with accounting standards, applicable laws, and regulations.

The Company's independent registered public accounting firm for Fiscal 2026 was UHY. UHY is responsible for performing an audit of the Company's consolidated financial statements in accordance with generally accepted auditing standards and expressing an opinion on the conformity of those financial statements with U.S. generally accepted accounting principles as well as performing a review of the interim financial statements for each of the first three fiscal quarters of Fiscal 2026. The Audit Committee has ultimate authority and responsibility for selecting, compensating, evaluating and, when appropriate, replacing, the Company's independent registered public accounting firm, and evaluates, based on the information available to it, the independence of that firm. The Audit Committee has the authority to engage its own outside counsel and other advisors, including experts in particular areas of accounting, as it determines appropriate, apart from counsel or advisors hired by the Company's management.

The Audit Committee members are not professional accountants or auditors, and the function of the Audit Committee is not intended to duplicate or to certify the activities of the Company's management or the Company's independent registered public accounting firm, nor can the Audit Committee certify that the independent registered public accounting firm is "independent" under applicable rules. The Audit Committee serves a Board-level oversight role in which it provides advice, counsel, and direction to the Company's management and to the auditors on the basis of the information it receives or develops, discussions with the Company's management and the auditors, and the experience of the Audit Committee's members in business, financial, and accounting matters.

The Audit Committee's agenda for the year includes reviewing the Company's financial statements, internal control over financial reporting, audit and other matters. In each of the first three quarters of Fiscal 2026, the Audit Committee met with the Company's independent registered public accounting firm and the Company's management to review the Company's interim financial results before the publication of the Company's quarterly earnings news releases and quarterly filings made with the Securities and Exchange Commission. The Company's management's and the independent registered public accounting firm's presentations to, and discussions with, the Audit Committee cover various topics and events that may have significant financial impact or are the subject of discussions between the Company's management and the independent registered public accounting audit firm. The Audit Committee reviews and discusses with the Company's management the Company's major financial risk exposures and the steps that the Company's management has taken to monitor and control such exposures. The Audit Committee is responsible for establishing procedures for the receipt, retention, and treatment of complaints received by the Company, the Board or the Audit Committee regarding accounting, internal accounting controls, or auditing matters, including confidential, anonymous submission by the Company's employees, received through established procedures, of any concerns regarding questionable accounting or auditing matters.

Among other matters, the Audit Committee monitors the activities and performance of the Company's independent registered public accounting firm, including the audit scope, external audit fees, auditor independence matters, and the extent to which the independent registered public accounting firm can be retained to perform non-audit services. In accordance with the Audit Committee charter and requirements of law, the Audit Committee pre-approves all services to be provided by the Company's independent registered public accounting firm. Pre-approval is required for audit services, audit-related services, tax services, and other services.

The Audit Committee has reviewed and discussed with the Company's management the audited financial statements of the Company for the fiscal year ended July 31, 2026, as well as the effectiveness of the Company's internal control over financial reporting as of July 31, 2026. UHY has provided the Audit Committee with the written disclosures and the letter required by the Public Company Accounting Oversight Board (PCAOB) regarding the independent registered public accounting firm's communications with the Audit Committee concerning independence, and the Audit Committee has discussed with UHY and management that firm's independence. The Audit Committee has also reviewed and discussed with UHY the matters required to be discussed with the independent registered public accounting firm by applicable PCAOB rules regarding "Communication with Audit Committees."

41

Based on these reviews and discussions, the Audit Committee recommended to the Board of Directors that the Company's audited financial statements for the fiscal year ended July 31, 2026 be included in the Company's Annual Report on Form 10-K for such fiscal year for filing with the Securities and Exchange Commission.

THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS

Gregory Suess, Chairman

Elliot Gibber

Paul Packer

Notwithstanding anything to the contrary set forth in any of the Company's previous filings under the Act, as amended, or the Exchange Act, as amended, that might incorporate future filings, including this Proxy Statement, in whole or in part, the foregoing report, as well as any charters or policies referenced within this Proxy Statement, shall not be incorporated by reference into any such filings, nor shall they be deemed to be soliciting material or deemed filed with the SEC under the Act or under the Exchange Act.

42

OTHER INFORMATION

Submission of Proposals for the 2028 Annual Meeting of Stockholders

Stockholders who wish to present proposals for inclusion in the Company's proxy materials in connection with its 2028 annual meeting of stockholders must submit such proposals in writing to the Corporate Secretary of the Company at 1178 Broadway, 3rd Floor #1450, New York, New York 10001, which proposals must be received at such address no later than August 4, 2027. In addition, any stockholder proposal submitted with respect to the Company's 2028 annual meeting of stockholders, which proposal is submitted outside the requirements of Rule 14a-8 under the Exchange Act and, therefore, will not be included in the relevant proxy materials, will be considered untimely for purposes of Rules 14a-4 and 14a-5 if written notice thereof is received by the Company's Corporate Secretary after October 18, 2027.

In addition, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company's nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than November 15, 2027. If the date of the 2028 annual meeting is more than 30 calendar days before or after January 14, 2028, such notice must instead be provided by the later of (i) 60 calendar days before the date of the 2028 annual meeting or (ii) the 10th calendar day following the day on which the Company first publicly announces the date of that meeting.

Availability of Annual Report on Form 10-K

Additional copies of the Company's Annual Report on Form 10-K for the fiscal year ended July 31, 2026 may be obtained by contacting Zedge Investor Relations, by phone at (330) 577-3424, or by mail addressed to Zedge Investor Relations at 1178 Broadway, 3rd Floor #1450, New York, New York 10001.

Other Matters

The Board of Directors knows of no other business that will be presented at the Annual Stockholders Meeting. If any other business is properly brought before the Annual Stockholders Meeting, it is intended that proxies granted will be voted in respect thereof in accordance with the judgments of the persons voting the proxies.

It is important that the proxies be returned promptly and that your shares be represented. Stockholders are urged to fill in, sign and promptly return the accompanying form in the enclosed envelope.

BY ORDER OF THE BOARD OF DIRECTORS

November [ ], 2026

Joyce J. Mason

Corporate Secretary

43

Exhibit A

ZEDGE, INC.
2026 EQUITY INCENTIVE PLAN

Adopted as of July 24, 2026

(Amended and Restated effective September 8, 2026)

Section 1. Purpose; Definitions.

The purposes of the Zedge, Inc. 2026 Equity Incentive Plan (as amended from time to time, the "Plan") are to: (a) enable Zedge, Inc. (the "Company") and its affiliated companies to recruit and retain highly qualified employees, directors and consultants; (b) provide those employees, directors and consultants with an incentive for productivity; and (c) provide those employees, directors and consultants with an opportunity to share in the growth and value of the Company.

For purposes of the Plan, the following terms will have the meanings defined below, unless the context clearly requires a different meaning:

"Affiliate" means, with respect to a Person, a Person that directly or indirectly controls, is controlled by, or is under common control with such Person.

"Applicable Law" means the legal requirements relating to the administration of and issuance of securities under stock incentive plans, including, without limitation, the requirements of state corporations law, federal, state and foreign securities law, federal, state and foreign tax law, and the requirements of any stock exchange or quotation system upon which the Shares may then be listed or quoted.

"Approval Date" has the meaning defined below in Section 19.

"Award" means an award of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units or Cash or Other Stock Based Awards made under this Plan.

"Award Agreement" means, with respect to any particular Award, the written document that sets forth the terms of that particular Award.

"Board" means the Board of Directors of the Company, as constituted from time to time.

"Cash or Other Stock Based Award" means an award that is granted under Section 10.

"Cause" means (i) the Participant's refusal to comply with any lawful directive or policy of the Company which refusal is not cured by the Participant within ten (10) days of such written notice from the Company; (ii) the Company's determination that the Participant has committed any act of dishonesty, embezzlement, unauthorized use or disclosure of confidential information or other intellectual property or trade secrets, common law fraud or other fraud against the Company or any Subsidiary or Affiliate; (iii) a material breach by the Participant of any written agreement with or any fiduciary duty owed to any Company or any Subsidiary or Affiliate; (iv) the Participant's conviction (or the entry of a plea of a nolo contendere or equivalent plea) of a felony or any misdemeanor involving material dishonesty or moral turpitude; or (v) the Participant's habitual or repeated misuse of, or habitual or repeated performance of Participant's duties under the influence of, alcohol, illegally obtained prescription controlled substances or non-prescription controlled substances. Notwithstanding the foregoing, if a Participant and the Company (or any of its Affiliates) have entered into an employment agreement, consulting agreement or other similar agreement that specifically defines "cause," then with respect to such Participant, "Cause" shall have the meaning defined in such other agreement.

"Change in Control" means the occurrence of any of the following events: (i) any "person," as such term is used in Sections 13(d) and 14(d) of the Exchange Act (other than (A) the Company, (B) any trustee or other fiduciary holding securities under an employee benefit plan of the Company, (C) any corporation or other entity owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of common stock of the Company, or (D) any Permitted Holder), is or becomes a "beneficial owner" (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the total power to vote for the election of directors of the Company; (ii) during any twelve-month period, individuals who at

A-1

the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in clause (i), (iii), (iv) or (v) of this definition) whose election by the Board or nomination for election by the Company's stockholders was approved by a vote of at least a majority of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority of the Board; (iii) the merger or consolidation of the Company with another entity where the stockholders of the Company immediately prior to the merger or consolidation will not beneficially own, immediately after the merger or consolidation, shares entitling such stockholders to 50% or more of all votes to which all stockholders of the surviving entity would be entitled in the election of directors (without consideration of the rights of any class of stock to elect directors by a separate class vote); (iv) the sale or other disposition of all or substantially all of the assets of the Company; (v) a liquidation or dissolution of the Company; or (vi) such other event deemed to constitute a "Change in Control" by the Board. For purposes of this definition, "Permitted Holder" means Michael Jonas, any Family Member of Michael Jonas, any trust solely for the benefit of Michael Jonas and/or any Family Member of Michael Jonas, any entity directly or indirectly controlled by any of the foregoing, or any group consisting solely of any of the foregoing. No Change in Control shall be deemed to occur solely as a result of any transfer of securities among Permitted Holders or any acquisition of securities by one or more Permitted Holders.

Notwithstanding anything in the Plan or an Award Agreement to the contrary, to the extent necessary to comply with Section 409A of the Code, no event that, but for the application of this paragraph, would be a Change in Control as defined in the Plan or the Award Agreement, as applicable, shall be a Change in Control for purposes of any Award subject to Section 409A of the Code unless such event is also a "change in control event" as defined in Section 409A of the Code.

"Code" means the Internal Revenue Code of 1986, as amended from time to time, and any successor thereto.

"Committee" means the committee authorized to administer the Plan under Section 2. To the extent required under Applicable Law, the Committee shall have at least two members and each member of the Committee shall be a Non-Employee Director. Unless otherwise determined by the Board, the Compensation Committee of the Board will serve as the Committee.

"Director" means a member of the Board.

"Disability" means a condition rendering a Participant Disabled.

"Disabled" means that a Participant is permanently and totally disabled within the meaning of Section 22(e)(3) of the Code.

"Effective Date" has the meaning defined below in Section 19.

"Exchange Act" means the Securities Exchange Act of 1934, as amended.

"Fair Market Value" means, as of any date, the value of a Share determined as follows: (i) if the Shares are listed on any established stock exchange or a national market system (including, without limitation, the NYSE American), the Fair Market Value of a Share will be the closing sales price for such stock as quoted on that exchange or system at the close of regular hours trading for the last preceding date on which there were sales of Shares on such exchange or system; (ii) if the Shares are regularly quoted by recognized securities dealers but selling prices are not reported, the Fair Market Value of a Share will be the mean between the high bid and low asked prices for Shares at the close of regular hours trading on the last preceding date; or (iii) if Shares are not traded as set forth above, the Fair Market Value will be determined in good faith by the Committee taking into consideration such factors as the Committee considers appropriate, such determination by the Committee to be final, conclusive and binding. Notwithstanding the foregoing, in connection with a Change in Control, Fair Market Value shall be determined in good faith by the Committee, such determination by the Committee to be final, conclusive and binding.

"Family Member" shall mean any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, aunt, uncle, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law (including adoptive relationships), any person sharing the household (other than a tenant or employee), a trust in which these persons have more than 50% of the beneficial interest, a foundation in which these persons control the management of assets, and any other entity in which these persons own more than 50% of the voting interests.

A-2

"Incentive Stock Option" means any Option intended to be an "Incentive Stock Option" within the meaning of Section 422 of the Code.

"Non-Employee Director" will have the meaning set forth in Rule 16b-3(b)(3)(i) promulgated by the Securities and Exchange Commission under the Exchange Act, or any successor definition adopted by the Securities and Exchange Commission.

"Non-Qualified Stock Option" means any Option that is not an Incentive Stock Option.

"Option" means any option to purchase Shares (including an option to purchase Restricted Stock, if the Committee so determines) granted pursuant to Section 5 hereof.

"Parent" means, in respect of the Company, a "parent corporation" as defined in Section 424(e) of the Code.

"Participant" means an employee, consultant, Director, or other service provider of or to the Company or any of its Affiliates to whom an Award is granted.

"Person" means an individual, partnership, corporation, limited liability company, trust, joint venture, unincorporated association, or other entity or association.

"Restricted Stock" means Shares that are subject to restrictions pursuant to Section 8 hereof.

"Restricted Stock Unit" means a right granted under and subject to restrictions pursuant to Section 9 hereof.

"Securities Act" means the Securities Act of 1933, as amended.

"Shares" means shares of the Company's Class B common stock, par value $0.01 per share, subject to substitution or adjustment as provided in Section 3(e) hereof.

"Stock Appreciation Right" means a right granted under and subject to Section 6 hereof.

"Subsidiary" means, in respect of the Company, a subsidiary company as defined in Sections 424(f) and (g) of the Code.

Section 2. Administration.

The Plan shall be administered by the Committee; provided, that, notwithstanding anything to the contrary herein, in its sole discretion, the Board may at any time, and from time to time, exercise any and all rights and duties of the Committee under the Plan except with respect to matters which under Applicable Law are required to be determined in the sole discretion of the Committee. Any action of the Committee in administering the Plan shall be final, conclusive and binding on all persons, including the Company, its Subsidiaries, Affiliates, their respective employees, the Participants, persons claiming rights from or through Participants and stockholders of the Company.

The Committee will have full authority to grant Awards under this Plan and determine the terms of such Awards. Such authority will include the right to: (a) select the individuals to whom Awards are granted (consistent with the eligibility conditions set forth in Section 4); (b) determine the type of Award to be granted; (c) determine the number of Shares, if any, to be covered by each Award; (d) establish the other terms and conditions of each Award; and (e) modify or amend each Award, subject to the Participant's consent if such modification or amendment would materially impair such Participant's rights.

The Committee will have the authority to adopt, alter and repeal such administrative rules, guidelines and practices governing the Plan as it, from time to time, deems advisable; to interpret the terms and provisions of the Plan and any Award issued under the Plan (and any Award Agreement); and to otherwise take any action that may be necessary or desirable to facilitate the administration of the Plan. The Committee may correct any defect, supply any omission or reconcile any inconsistency in the Plan or in any Award Agreement in the manner and to the extent it deems necessary to carry out the intent of the Plan.

To the extent permitted by Applicable Law, the Committee may delegate to one or more officers of the Company the authority to grant Awards to employees of the Company or its Subsidiaries who are not executive officers of the Company subject to the requirements of Section 16 of the Exchange Act and the rules and regulations thereunder. The Committee may revoke any such delegation at any time for any reason with or without prior notice.

A-3

No Director will be liable for any good faith determination, act or omission in connection with the Plan or any Award.

Section 3. Shares Subject to the Plan.

(a) Shares Subject to the Plan. Subject to adjustment as provided in this Section 3, the maximum number of Shares that may be issued in respect of Awards under the Plan is 2,121,552 Shares, consisting of (i) 288,695 Shares that remained available for issuance under the Zedge, Inc. 2016 Stock Option and Incentive Plan, as amended (the "Prior Plan"), and were not subject to outstanding awards as of the expiration of the Prior Plan, plus (ii) 1,250,000 additional Shares, plus (iii) any Shares subject to awards outstanding under the Prior Plan as of the Effective Date that, after the Effective Date, expire, are cancelled or forfeited, are settled in cash, or otherwise terminate without the issuance of Shares, up to a maximum of 582,857 Shares.

No further awards may be granted under the Prior Plan after its expiration. Awards outstanding under the Prior Plan shall remain outstanding and continue to be governed by the terms of the Prior Plan and the applicable award agreements evidencing such awards.

Any Shares issued under the Plan may consist, in whole or in part, of authorized and unissued Shares or treasury shares. Any Shares issued in respect of Awards granted in substitution for equity-based awards of an entity acquired by the Company or a Subsidiary, or with which the Company or a Subsidiary combines, shall not reduce the maximum number of Shares available for delivery under the Plan.

(b) Incentive Stock Option Limit. Subject to adjustment as provided in this Section 3, the maximum aggregate number of Shares that may be issued pursuant to the exercise of Incentive Stock Options granted under the Plan is 100,000 Shares.

(c) Effect of the Expiration or Termination of Awards. If and to the extent that an Option or a Stock Appreciation Right expires, terminates or is canceled or forfeited for any reason without having been exercised in full, the Shares associated with that Award will again become available for grant under the Plan. Similarly, if and to the extent an Award of Restricted Stock or Restricted Stock Units is canceled or forfeited for any reason, the Shares subject to that Award will again become available for grant under the Plan.

(d) Shares Withheld in Satisfaction of Taxes or Exercise Price. Shares withheld in settlement of a tax withholding obligation associated with an Award, or in satisfaction of the exercise price payable upon exercise of an Option, will again become available for grant under the Plan.

(e) Other Adjustment. In the event of any corporate event or transaction such as a merger, consolidation, reorganization, recapitalization, stock split, reverse stock split, split up, spin-off, combination of shares, exchange of shares, stock dividend, dividend in kind, or other like change in capital structure (other than ordinary cash dividends) to stockholders of the Company, or other similar corporate event or transaction affecting the Shares, the Committee, to prevent dilution or enlargement of Participants' rights under the Plan, shall, in such manner as it deems equitable, substitute or adjust, in its sole discretion, the number and kind of shares that may be issued under the Plan or under any outstanding Awards, the number and kind of shares subject to outstanding Awards, the exercise price, grant price or purchase price applicable to outstanding Awards, and/or any other affected terms and conditions of this Plan or outstanding Awards.

(f) Change in Control. Notwithstanding anything to the contrary set forth in the Plan, upon or in anticipation of any Change in Control, the Committee may, in its sole and absolute discretion and without the need for the consent of any Participant, take one or more of the following actions contingent upon the occurrence of that Change in Control: (i) cause any or all outstanding Awards to become vested and immediately exercisable (as applicable), in whole or in part; (ii) cause any outstanding Option or Stock Appreciation Right to become fully vested and immediately exercisable for a reasonable period in advance of the Change in Control and, to the extent not exercised prior to that Change in Control, cancel that Option or Stock Appreciation Right upon closing of the Change in Control; (iii) cancel any unvested Award or unvested portion thereof, with or without consideration; (iv) cancel any Award in exchange for a substitute award; (v) redeem any Restricted Stock or Restricted Stock Unit for cash and/or other substitute consideration with value equal to the Fair Market Value of an unrestricted Share on the date of the Change in Control; (vi) cancel any Option or Stock Appreciation Right in exchange for cash and/or other substitute consideration with a value equal to: (A) the number of Shares

A-4

subject to that Option or Stock Appreciation Right, multiplied by (B) the difference, if any, between the Fair Market Value on the date of the Change in Control and the exercise price of that Option or the base price of the Stock Appreciation Right; provided, that if the Fair Market Value on the date of the Change in Control does not exceed the exercise price of any such Option or the base price of any such Stock Appreciation Right, the Committee may cancel that Option or Stock Appreciation Right without any payment of consideration therefor; and/or (vii) take such other action as the Committee determines to be appropriate under the circumstances. In the discretion of the Committee, any cash or substitute consideration payable upon cancellation of an Award may be subjected to (x) vesting terms substantially identical to those that applied to the cancelled Award immediately prior to the Change in Control, or (y) earn-out, escrow, holdback or similar arrangements, to the extent such arrangements are applicable to any consideration paid to stockholders in connection with the Change in Control. Notwithstanding any provision of this Section 3(f), in the case of any Award subject to Section 409A of the Code, the Committee shall only be permitted to take actions under this Section 3(f) to the extent that such actions would be consistent with the intended treatment of such Award under Section 409A of the Code.

(g) Foreign Holders. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws in countries other than the United States in which the Company and its Subsidiaries operate or have employees, directors and consultants, or in order to comply with the requirements of any foreign securities exchange or other Applicable Law, the Committee, in its sole discretion, shall have the power and authority to: (i) modify the terms and conditions of any Award granted to employees, directors and consultants outside the United States to comply with Applicable Law (including, without limitation, applicable foreign laws or listing requirements of any foreign securities exchange); (ii) establish subplans and modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable; provided, however, that no such subplans and/or modifications shall increase the share limitations contained in Section 3; and (iii) take any action, before or after an Award is made, that it deems advisable to obtain approval or comply with any necessary local governmental regulatory exemptions or approvals or listing requirements of any foreign securities exchange.

(h) Annual Compensation Limitations for Non-Employee Directors. Beginning with the first fiscal year following the year in which the Approval Date occurs, the aggregate amount of equity and cash compensation (collectively "Compensation") payable to a Non-Employee Director with respect to a fiscal year, whether under the Plan or otherwise, for services as a Non-Employee Director, shall not exceed $750,000; provided, however, that such amount shall be $1,000,000 for the fiscal year in which the applicable Non-Employee Director is initially elected or appointed to the Board (collectively, the "Director Limit"). Equity incentive awards shall be counted towards the Director Limit in the year in which they are granted, based on the grant-date fair value of such awards for financial reporting purposes (but excluding the impact of estimated forfeitures related to service-based vesting provisions). Cash fees shall be counted towards the Director Limit in the year for which they are reported as compensation in the Company's director compensation disclosures pursuant to Item 402 of Regulation S-K under the Securities Act, or a successor provision. The Director Limit shall not apply to (i) Compensation earned by a Non-Employee Director solely in his or her capacity as chairperson of the Board or lead independent director; (ii) Compensation earned with respect to services a Non-Employee Director provides in a capacity other than as a Non-Employee Director, such as an advisor or consultant to the Company; and (iii) Compensation awarded by the Board to a Non-Employee Director in extraordinary circumstances, as determined by the Board in its discretion, in each case provided that the Non-Employee Director receiving such additional Compensation does not participate in the decision to award such Compensation.

Section 4. Eligibility.

Employees, Directors, consultants and other persons who provide services to the Company or its Affiliates are eligible to be granted Awards under the Plan; provided that such persons are eligible to be issued securities of the Company registered on Form S-8 or exempt from registration under Rule 701 under the Securities Act, as applicable (or any successor provision). However, only employees of the Company, any Parent or a Subsidiary are eligible to be granted Incentive Stock Options.

A-5

Section 5. Options.

Options granted under the Plan may be of two types: (i) Incentive Stock Options or (ii) Non-Qualified Stock Options. The Award Agreement shall state whether such grant is an Incentive Stock Option or a Non-Qualified Stock Option.

The Award Agreement evidencing any Option will incorporate the following terms and conditions and will contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee deems appropriate in its sole and absolute discretion:

(a) Option Price. The exercise price per Share under an Option will be determined by the Committee but will not be less than 100% of Fair Market Value on the date of grant; provided, that the foregoing minimum exercise price shall not apply to an Option granted in substitution for an outstanding option of an entity acquired by, or combined with, the Company or a Subsidiary, to the extent such substitution is effected in a manner described in Section 424(a) of the Code and, in the case of a Non-Qualified Stock Option, that also satisfies the requirements of Section 409A of the Code. Any Incentive Stock Option granted to any Participant who, at the time the Option is granted, owns, either directly and/or within the meaning of the attribution rules contained in Section 424(d) of the Code, stock possessing more than 10% of the total combined voting power of all classes of stock of the Company, will have an exercise price per Share of not less than 110% of Fair Market Value on the date of the grant.

Notwithstanding the minimum exercise price requirement of this Section 5(a), the Committee may grant a Non-Qualified Stock Option with an exercise price below Fair Market Value on the date of grant only where the Committee expressly determines at the time of grant that the Option is intended to be exempt from, or to satisfy the requirements of, Section 409A of the Code, and the applicable Award Agreement sets forth the exercise, payment and settlement terms necessary for such exemption or compliance.

(b) Option Term. The term of each Option will be fixed by the Committee, but no Option will be exercisable more than 10 years after the date the Option is granted. However, any Incentive Stock Option granted to any Participant who, at the time such Option is granted, owns stock, either directly and/or within the meaning of the attribution rules contained in Section 424(d) of the Code, possessing more than 10% of the total combined voting power of all classes of stock of the Company, may not have a term of more than 5 years. No Option may be exercised by any Person after expiration of the term of the Option. Unless otherwise specified by the Committee or required by the second sentence of this paragraph, each Option will have a term of 10 years (subject to earlier termination in accordance with other provisions of this Plan and the applicable Award Agreement).

(c) Exercisability. Options will vest and be exercisable at such time or times and subject to such terms and conditions as determined by the Committee. Such terms and conditions may include the continued employment or service of the Participant, the attainment of specified individual or corporate performance goals, or such other factors as the Committee may determine in its sole discretion (the "Vesting Conditions"). The Committee may provide in the terms of an Award Agreement that the Participant may exercise the unvested portion of an Option in whole or in part in exchange for shares of Restricted Stock subject to the same vesting terms as the portion of the Option so exercised. Restricted Stock acquired upon the exercise of an unvested Option shall be subject to such additional terms and conditions as determined by the Committee.

(d) Method of Exercise. Subject to the terms of the applicable Award Agreement, the exercisability provisions of Section 5(c) and the termination provisions of Section 7, Options may be exercised in whole or in part from time to time during their term by the delivery of written notice to the Company specifying the number of Shares to be purchased. Such notice will be accompanied by payment in full of the purchase price and any taxes required to be withheld in connection with such exercise, either by certified or bank check, in the manner described in the next sentence, or by such other means as the Committee may accept. Unless otherwise determined by the Committee (which determination may be made at any time), payment of the exercise price of an Option may be paid in the form of previously acquired Shares based on the Fair Market Value of the Shares on the date the Option is exercised or by means of a "net settlement," whereby the Option exercise price will not be due in cash and where the number of Shares issued upon such exercise will be equal to: (A) the product of (i) the number of Shares as to which the Option is then being exercised, and (ii) the excess, if any, of (a) the then current Fair Market Value over (b) the Option exercise price, divided by (B) the then current Fair Market Value.

A-6

An Option will not confer upon the Participant any of the rights or privileges of a stockholder in the Company unless and until the Participant exercises the Option in accordance with this Section 5(d) and is issued Shares pursuant to such exercise.

(e) Incentive Stock Option Limitations. In the case of an Incentive Stock Option, the aggregate Fair Market Value (determined as of the time of grant) of the Shares with respect to which Incentive Stock Options are exercisable for the first time by the Participant during any calendar year under the Plan and/or any other plan of the Company, its Parent or any Subsidiary will not exceed $100,000. For purposes of applying the foregoing limitation, Incentive Stock Options will be taken into account in the order granted. To the extent any Option does not meet such limitation, that Option will be treated for all purposes as a Non-Qualified Stock Option.

(f) Termination of Service. Unless otherwise specified in the applicable Award Agreement or as otherwise provided by the Committee at or after the time of grant, Options will be subject to the terms of Section 7 with respect to exercise upon or following termination of employment or other service.

Section 6. Stock Appreciation Rights.

Subject to the other terms of the Plan, the Committee may grant Stock Appreciation Rights to eligible individuals. Each Stock Appreciation Right shall represent the right to receive, upon exercise, an amount equal to the number of Shares subject to the Award that is being exercised multiplied by the excess of (i) the Fair Market Value on the date the Award is exercised, over (ii) the base price specified in the applicable Award Agreement. Distributions may be made in cash, Shares, or a combination of both, at the discretion of the Committee. The Award Agreement evidencing each Stock Appreciation Right shall indicate the base price, the term and the Vesting Conditions for such Award. A Stock Appreciation Right base price may never be less than the Fair Market Value of an underlying Share of the Company on the date of grant of such Stock Appreciation Right. The term of each Stock Appreciation Right will be fixed by the Committee, but no Stock Appreciation Right will be exercisable more than 10 years after the date the Stock Appreciation Right is granted. Subject to the terms and conditions of the applicable Award Agreement, Stock Appreciation Rights may be exercised in whole or in part from time to time during their term by the delivery of written notice to the Company specifying the portion of the Award to be exercised. Unless otherwise specified in the applicable Award Agreement or as otherwise provided by the Committee at or after the time of grant, Stock Appreciation Rights will be subject to the terms of Section 7 with respect to exercise upon or following termination of employment or other service.

Section 7. Termination of Service.

Unless otherwise specified with respect to a particular Option or Stock Appreciation Right in the applicable Award Agreement or otherwise determined by the Committee, any portion of an Option or Stock Appreciation Right that is not exercisable upon termination of service will expire immediately and automatically upon such termination and any portion of an Option or Stock Appreciation Right that is exercisable upon termination of service will expire on the date it ceases to be exercisable in accordance with this Section 7.

(a) Termination by Reason of Death. If a Participant's service with the Company or any Affiliate terminates by reason of death, any Option or Stock Appreciation Right held by such Participant may thereafter be exercised, to the extent it was exercisable at the time of his or her death or on such accelerated basis as the Committee may determine at or after grant, by the legal representative of the estate or by the legatee of the Participant, for a period expiring (i) at such time as may be specified by the Committee at or after grant, or (ii) if not specified by the Committee, then 12 months from the date of death, or (iii) if sooner than the applicable period specified under (i) or (ii) above, upon the expiration of the stated term of such Option or Stock Appreciation Right.

(b) Termination by Reason of Disability. If a Participant's service with the Company or any Affiliate terminates by reason of Disability, any Option or Stock Appreciation Right held by such Participant may thereafter be exercised by the Participant or his or her personal representative, to the extent it was exercisable at the time of termination, or on such accelerated basis as the Committee may determine at or after grant, for a period expiring (i) at such time as may be specified by the Committee at or after grant, or (ii) if not specified by the Committee, then 12 months from the date of termination of service, or (iii) if sooner than the applicable period specified under (i) or (ii) above, upon the expiration of the stated term of such Option or Stock Appreciation Right.

A-7

(c) Cause. If a Participant's service with the Company or any Affiliate is terminated for Cause or if a Participant resigns at a time that there was a Cause basis for such Participant's termination: (i) any Option or Stock Appreciation Right, or portion thereof, not already exercised will be immediately and automatically forfeited as of the date of such termination, and (ii) any Shares that the Company has not yet delivered will be immediately and automatically forfeited and the Company will refund to the Participant the Option exercise price paid for such Shares, if any.

(d) Other Termination. If a Participant's service with the Company or any Affiliate terminates for any reason other than death, Disability or Cause, any Option or Stock Appreciation Right held by such Participant may thereafter be exercised by the Participant, to the extent it was exercisable at the time of such termination, or on such accelerated basis as the Committee may determine at or after grant, for a period expiring (i) at such time as may be specified by the Committee at or after grant, or (ii) if not specified by the Committee, then 90 days from the date of termination of service, or (iii) if sooner than the applicable period specified under (i) or (ii) above, upon the expiration of the stated term of such Option or Stock Appreciation Right.

Section 8. Restricted Stock.

(a) Issuance. Restricted Stock may be issued either alone or in conjunction with other Awards. The Committee will determine the time or times within which Restricted Stock may be subject to forfeiture, and all other conditions of such Awards. The purchase price for Restricted Stock may, but need not, be zero.

(b) Restrictions and Conditions. The Award Agreement evidencing the grant of any Restricted Stock will incorporate the following terms and conditions and such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee deems appropriate in its sole and absolute discretion: (i) During a period commencing with the date of an Award of Restricted Stock and ending at such time or times as specified by the Committee (the "Restriction Period"), the Participant will not be permitted to sell, transfer, pledge, assign or otherwise encumber Restricted Stock awarded under the Plan. The Committee may condition the lapse of restrictions on Restricted Stock upon one or more Vesting Conditions. (ii) While any Share of Restricted Stock remains subject to restriction, the Participant will have, with respect to the Restricted Stock, the right to vote the Shares. If any cash distributions or dividends are payable with respect to the Restricted Stock, the cash distributions or dividends will be subjected to the same Restriction Period as is applicable to the Restricted Stock with respect to which such amounts are paid, or, if the Committee so determines, reinvested in additional Restricted Stock, to the extent Shares are available under Section 3 of the Plan. A Participant shall not be entitled to interest with respect to any dividends or distributions subjected to the Restriction Period. Any distributions or dividends paid in the form of securities with respect to Restricted Stock will be subject to the same terms and conditions as the Restricted Stock with respect to which they were paid, including, without limitation, the same Restriction Period.

(c) Forfeiture. Subject to the provisions of the applicable Award Agreement or as otherwise determined by the Committee, if a Participant's service with the Company and its Affiliates terminates prior to the expiration of the applicable Restriction Period, the Participant's Restricted Stock that then remains subject to forfeiture will then be forfeited automatically.

Section 9. Restricted Stock Units.

Subject to the other terms of the Plan, the Committee may grant Restricted Stock Units to eligible individuals and may impose one or more Vesting Conditions on such units. Each Restricted Stock Unit will represent a right to receive from the Company, upon fulfillment of any applicable conditions, an amount equal to the Fair Market Value (at the time of the distribution). Distributions may be made in cash, Shares, or a combination of both, at the discretion of the Committee. The Award Agreement evidencing a Restricted Stock Unit shall set forth the Vesting Conditions and time and form of payment with respect to such Award. The Participant shall not have any stockholder rights with respect to the Shares subject to a Restricted Stock Unit Award until that Award vests and the Shares are actually issued thereunder; provided, however, that an Award Agreement may provide for the inclusion of dividend equivalent payments or unit credits with respect to the Award in the discretion of the Committee. Subject to the provisions of the applicable Award Agreement or as otherwise determined by the Committee, if a Participant's service with the Company terminates prior to the Restricted Stock Unit Award vesting in full, any portion of the Participant's Restricted Stock Units that then remain subject to forfeiture will then be forfeited automatically.

A-8

Section 10. Cash or Other Stock Based Awards.

Subject to the other terms of the Plan, the Committee may grant Cash or Other Stock Based Awards (including Awards to receive unrestricted Shares or immediate cash payments) to eligible individuals. The Award Agreement evidencing a Cash or Other Stock Based Award shall set forth the terms and conditions of such Cash or Other Stock Based Award, including, as applicable, the term, any exercise or purchase price, performance goals, Vesting Conditions and other terms and conditions. Payment in respect of a Cash or Other Stock Based Award may be made in cash, Shares, or a combination of cash and Shares, as determined by the Committee.

Section 11. Amendments and Termination.

Subject to any stockholder approval that may be required under Applicable Law, the Plan may be amended or terminated at any time or from time to time by the Board.

Section 12. Repricing Permitted.

The Committee may reprice Options or Stock Appreciation Rights without stockholder approval, whether such repricing is accomplished by (i) means of a cancellation/re-grant program pursuant to which outstanding Options or Stock Appreciation Rights are cancelled and new Options or Stock Appreciation Rights are granted in replacement with a lower exercise or base price per share, (ii) cancellation of outstanding Options or Stock Appreciation Rights with exercise prices or base prices per share in excess of the then current Fair Market Value for consideration payable in equity securities of the Company or cash, (iii) directly or indirectly reducing the exercise price or base price of outstanding Options or Stock Appreciation Rights, or (iv) any other method.

Section 13. Conditions Upon Grant of Awards and Issuance of Shares.

(a) The implementation of the Plan, the grant of any Award and the issuance of Shares in connection with the issuance, exercise or vesting of any Award made under the Plan shall be subject to the Company's procurement of all approvals and permits required by regulatory authorities having jurisdiction over the Plan, the Awards made under the Plan and the Shares issuable pursuant to those Awards.

(b) No Shares or other assets shall be issued or delivered under the Plan unless and until there shall have been compliance with all applicable requirements of Applicable Law.

(c) If the Company cannot, by the exercise of commercially reasonable efforts, obtain authority from any regulatory body having jurisdiction over the issuance or sale of Shares under this Plan, and such authority is deemed by the Company's counsel to be necessary to the lawful issuance of those Shares, the Company will be relieved of any liability for failing to issue or sell those Shares.

Section 14. Limits on Transferability; Beneficiaries.

No Award or other right or interest of a Participant under the Plan shall be pledged, encumbered, or hypothecated to, or in favor of, or subject to any lien, obligation, or liability of such Participant to, any party, other than the Company, any Subsidiary or Affiliate, or assigned or transferred by such Participant other than by will or the laws of descent and distribution, and such Awards and rights shall be exercisable during the lifetime of the Participant only by the Participant or his or her guardian or legal representative. Notwithstanding the foregoing, the Committee may, in its discretion, provide that Awards or other rights or interests of a Participant granted pursuant to the Plan (other than an Incentive Stock Option) be transferable, without consideration, to immediate family members (i.e., children, grandchildren or spouse), to trusts for the benefit of such immediate family members, to partnerships in which such family members are the only partners, to other similar estate planning vehicles, or to such other transferees as the Committee permits (taking into account the restrictions or requirements of applicable tax, securities and other laws). The Committee may attach to such transferability feature such terms and conditions as it deems advisable. In addition, a Participant may, in the manner established by the Committee, designate a beneficiary (which may be a person or a trust) to exercise the rights of the Participant, and to receive any distribution, with respect to any Award upon the death of the Participant. A beneficiary, guardian, legal representative or other person claiming any rights under the Plan from or through any Participant shall be subject to all terms and conditions of the Plan and any Award Agreement applicable to such Participant, except as otherwise determined by the Committee, and to any additional restrictions deemed necessary or appropriate by the Committee.

A-9

Section 15. Withholding of Taxes.

No later than the date as of which an amount first becomes includible in the gross income of the Participant for federal income tax purposes with respect to any Award under the Plan, the Participant will pay to the Company, or make arrangements satisfactory to the Company regarding the payment of, any federal, state or local taxes of any kind required by law to be withheld with respect to such amount. To the extent authorized by the Committee, the required tax withholding may be satisfied by the withholding of Shares subject to the Award based on the fair market value of those Shares, as determined by the Company, but in any case not in excess of the amount determined based on the maximum statutory tax rate in the applicable jurisdiction. The obligations of the Company under the Plan will be conditioned on such payment or arrangements and the Company will have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant.

Section 16. General Provisions.

(a) The Committee may require each Participant to represent to and agree with the Company in writing that the Participant is acquiring securities of the Company for investment purposes and without a view to distribution thereof and as to such other matters as the Committee believes are appropriate.

(b) The Awards, and any Shares subject thereto, will be subject to the Company's stock ownership, securities trading, anti-hedging and other similar policies as in effect from time to time.

(c) All Shares or other securities delivered under the Plan will be subject to such stop-transfer orders and other restrictions as the Board may deem necessary to reflect the terms of the applicable Award or advisable to comply with the rules, regulations and other requirements of the Securities Act, the Exchange Act, any stock exchange upon which the Shares are then listed, and any other Applicable Law.

(d) Nothing contained in the Plan will prevent the Company from adopting other or additional compensation arrangements, subject to stockholder approval if such approval is required.

(e) Neither the adoption of the Plan nor the execution of any document in connection with the Plan will: (i) confer upon any employee or other service provider of the Company or an Affiliate any right to continued employment or engagement with the Company or such Affiliate, or (ii) interfere in any way with the right of the Company or such Affiliate to terminate the employment or engagement of any of its employees or other service providers at any time.

(f) The Awards (whether vested or unvested) shall be subject to rescission, cancellation, forfeiture, recoupment or other recovery, in whole or in part, under any current or future "clawback" or similar policy of the Company that is applicable to the Participant, under Section 18, or under any applicable Award Agreement. Notwithstanding any other provisions in this Plan, any Award which is subject to recovery under any law, government regulation or stock exchange listing requirement will be subject to such deductions and clawback as may be required to be made pursuant to such law, government regulation or stock exchange listing requirement.

Section 17. Section 409A.

It is intended that the Plan and each Award be exempt from or comply with Section 409A of the Code, and the Plan and each Award Agreement shall be interpreted and administered accordingly. Each payment under any Award shall be treated as a separate payment for purposes of Section 409A of the Code. To the extent an Award is intended to qualify as a "short-term deferral" within the meaning of Section 409A of the Code, the amount payable under such Award shall be paid or settled not later than the fifteenth (15th) day of the third month following the end of the later of the Participant's or the Company's taxable year in which the Award (or the applicable portion thereof) is no longer subject to a substantial risk of forfeiture. Any Award that provides for the deferral of compensation subject to Section 409A of the Code shall be structured to satisfy the requirements of Section 409A of the Code, including as to the time and form of payment, and any amount payable under such an Award upon a termination of service shall be paid only upon a "separation from service" within the meaning of Section 409A of the Code. Notwithstanding anything in the Plan to the contrary, if a Participant is a "specified employee" within the meaning of Section 409A of the Code as of the date of his or her separation from service, then, to the extent required to avoid the imposition of additional tax under Section 409A of the Code, any payment of nonqualified deferred compensation (within the meaning of Section 409A of the Code) that is payable on account of such separation from service shall be delayed and

A-10

paid in a lump sum on the first business day of the seventh month following such separation from service (or, if earlier, upon the Participant's death). Neither the Company nor any Affiliate, nor any of their respective directors, officers, employees or agents, shall have any liability to any Participant or any other person if any Award that is intended to be exempt from, or compliant with, Section 409A of the Code is not so exempt or compliant, and none of the foregoing guarantees any particular tax treatment.

Section 18. Forfeiture upon Breach of Restrictive Covenants.

The Committee may condition a Participant's right to receive, vest in, retain or realize any benefit or gain in respect of an Award upon the Participant's compliance with any non-competition, non-solicitation, confidentiality, non-disparagement, invention-assignment, return-of-property or other restrictive covenant set forth in the applicable Award Agreement or in any other written agreement between the Participant and the Company or an Affiliate.

Without limiting the foregoing, to the fullest extent permitted by Applicable Law, if a Participant voluntarily terminates service with the Company or an Affiliate and thereafter competes with the Company or any Affiliate, or if a Participant breaches any applicable confidentiality, non-solicitation or other restrictive covenant, the Committee may provide in the applicable Award Agreement that the Participant shall forfeit outstanding Awards, whether vested or unvested, and/or repay to the Company any Shares, cash or other gain realized in respect of any Award during the period specified in the applicable Award Agreement.

The remedies provided in this Section 18 shall be in addition to, and not in limitation of, any rights or remedies available to the Company or any Affiliate under the Plan, any Award Agreement, any other written agreement, any Company policy or Applicable Law, including the rescission, cancellation and recoupment provisions of Section 16(f). This Section 18 shall be interpreted and applied to the maximum extent enforceable under Applicable Law.

Section 19. Effectiveness of Plan.

The Plan was adopted by the Board on July 24, 2026 (the "Effective Date"), subject to approval by the stockholders of the Company. The Board amended the Plan on September 8, 2026 to increase the amount of authorized shares under the Plan by 1,100,000 Shares, subject to approval by the stockholders of the Company. Notwithstanding any other provision of the Plan: (i) the Plan, and all Awards granted under the Plan, are expressly conditioned upon, and subject to, approval of the Plan and the amendment by the affirmative vote of the holders of the requisite number of the Company's outstanding voting securities at the Company's annual meeting of stockholders to be held on January 14, 2027 (or any adjournment or postponement thereof, or any special meeting held in lieu thereof) (the date of such approval, the "Approval Date"); (ii) no Option or Stock Appreciation Right may be exercised, no Restricted Stock Unit or Cash or Other Stock Based Award may be settled, and no Shares may be issued or delivered under the Plan (including in respect of Restricted Stock), unless and until the Approval Date occurs; and (iii) if the stockholders of the Company do not approve the Plan within twelve (12) months after the Effective Date, the Plan shall terminate and all Awards granted under it shall automatically terminate and be cancelled without consideration.

Section 20. Term of Plan.

Unless extended with the approval of the stockholders of the Company, the Plan shall terminate on the 10-year anniversary of the Effective Date, and no Awards shall thereafter be granted under the Plan. Awards outstanding upon the termination of the Plan shall remain outstanding in accordance with their terms.

Section 21. Invalid Provisions.

In the event that any provision of this Plan is found to be invalid or otherwise unenforceable under any Applicable Law, such invalidity or unenforceability will not be construed as rendering any other provisions contained herein as invalid or unenforceable, and all such other provisions will be given full force and effect to the same extent as though the invalid or unenforceable provision was not contained herein.

Section 22. Governing Law.

The Plan and all Awards granted hereunder will be governed by and construed in accordance with the laws and judicial decisions of the State of Delaware, without regard to the application of the principles of conflicts of laws.

A-11

ANNUAL MEETING OF STOCKHOLDERS OF
ZEDGE, INC.

January 14, 2027

Important Notice Regarding the Availability of Proxy Materials for the Zedge, Inc.
Stockholders Meeting to be Held on January 14, 2027:

The Notice of Annual Meeting of Stockholders and Proxy Statement and the Fiscal 2026 Annual Report are available at:

http://investor.zedge.net

Please date, sign and mail
your proxy card in the
envelope provided as soon
as possible.

â Please detach along perforated line and mail in the envelope provided. â

PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK
YOUR VOTES IN BLUE OR BLACK INK AS SHOWN HERE
☒

THE BOARD OF DIRECTORS RECOMMENDS VOTES "FOR" THE LISTED NOMINEES AND "FOR" PROPOSALS 2, 3 AND 4

FOR

AGAINST

ABSTAIN

FOR

AGAINST

ABSTAIN

1. Election of Directors:

2. To approve the adoption of the Zedge, Inc. 2026 Equity Incentive Plan and an amendment to increase the number of shares of the Company's Class B Common Stock available for the grant of awards thereunder to 1,538,695 shares.

☐

☐

☐

NOMINEES:

3. To approve the issuance of the Company's Class B Common Stock warrants issued in the Company's September 2026 private placement and the shares of the Company's Class B Common Stock issuable upon their exercise.

☐

☐

☐

Mark Ghermezian

☐

☐

☐

4. To ratify the appointment of UHY LLP as the Company's independent registered public accounting firm for the Fiscal Year ending July 31, 2027.

☐

☐

☐

Elliot Gibber

☐

☐

☐

5. To transact other business as may properly come before the Annual Meeting of Stockholders and any adjournment or postponement thereof.

Howard S. Jonas

☐

☐

☐

Michael Jonas

☐

☐

☐

Paul Packer

☐

☐

☐

Gregory Suess

☐

☐

☐

To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.

☐

MARK "X" HERE IF YOU PLAN TO ATTEND THE MEETING.

☐

Signature of Stockholder ______________

Date: __________

Signature of Stockholder _____________

Date: __________

Note: Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by a duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by an authorized person.

Electronic Distribution

If you would like to receive future ZEDGE, INC. proxy statements and annual reports electronically, please visit www.amstock.com. Click on Shareholder Account Access to enroll. Please enter your account number and tax identification number to log in, then select Receive Company Mailings via e-Mail and provide your e-mail address.

THIS PROXY IS BEING SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF
ZEDGE, INC.
1178 Broadway, 3
rd Floor #1450, New York, New York 10001
(330) 577
-3424
PROXY FOR ANNUAL MEETING OF STOCKHOLDERS
To Be Held January 14, 2027

The undersigned appoints Michael Jonas and Joyce J. Mason, or either one of them, as the proxy of the undersigned with full power of substitution to attend and vote at the Annual Meeting of Stockholders (the "Annual Stockholders Meeting") of Zedge, Inc. to be held at Insperity Conference Room, 1177 6th Avenue, 35th floor, New York, New York 10036 on January 14, 2027 at 12:00 p.m., and any adjournment or postponement of the Annual Stockholders Meeting, according to the number of votes the undersigned would be entitled to cast if personally present, for or against any proposal, including the election of members of the Board of Directors, and any and all other business that may come before the Annual Stockholders Meeting, except as otherwise indicated on the reverse side of this card.

THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED BY THE UNDERSIGNED STOCKHOLDER.

CONTINUED AND TO BE SIGNED ON REVERSE SIDE

ANNUAL MEETING OF STOCKHOLDERS OF
ZEDGE, INC.

JANUARY 14, 2027

PROXY VOTING INSTRUCTIONS

INTERNET - Access "www.voteproxy.com" and follow the on-screen instructions or scan the QR code with your smartphone. Have your proxy card available when you access the web page.

Vote online until 11:59 PM EST the day before the meeting.

MAIL - Date, sign and mail your proxy card in the envelope provided as soon as possible.

IN PERSON - You may vote your shares in person by attending the Annual Stockholders Meeting.

COMPANY NUMBER __________________

GO GREEN - e-Consent makes it easy to go paperless. With e-Consent, you can quickly access your proxy material, statements and other eligible documents online, while reducing costs, clutter and paper waste. Enroll today via www.amstock.com to enjoy online access.

ACCOUNT NUMBER __________________

â Please detach along perforated line and mail in the envelope provided IF you are not voting via the Internet. â

PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK
YOUR VOTES IN BLUE OR BLACK INK AS SHOWN HERE ☒

THE BOARD OF DIRECTORS RECOMMENDS VOTES "FOR" THE LISTED NOMINEES AND "FOR" PROPOSALS 2, 3 AND 4

FOR

AGAINST

ABSTAIN

FOR

AGAINST

ABSTAIN

1. Election of Directors:

2. To approve the adoption of the Zedge, Inc. 2026 Equity Incentive Plan and an amendment to increase the number of shares of the Company's Class B Common Stock available for the grant of awards thereunder to 1,538,695 shares.

☐

☐

☐

NOMINEES:

3. To approve the issuance of the Company's Class B Common Stock warrants issued in the Company's September 2026 private placement and the shares of the Company's Class B Common Stock issuable upon their exercise.

☐

☐

☐

Mark Ghermezian

☐

☐

☐

4. To ratify the appointment of UHY LLP as the Company's independent registered public accounting firm for the Fiscal Year ending July 31, 2027.

☐

☐

☐

Elliot Gibber

☐

☐

☐

5. To transact other business as may properly come before the Annual Meeting of Stockholders and any adjournment or postponement thereof.

Howard S. Jonas

☐

☐

☐

Michael Jonas

☐

☐

☐

Paul Packer

☐

☐

☐

Gregory Suess

☐

☐

☐

To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.

☐

MARK "X" HERE IF YOU PLAN TO ATTEND THE MEETING.

☐

Signature of Stockholder ______________

Date: __________

Signature of Stockholder _____________

Date: __________

Note: Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by a duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by an authorized person.

Zedge Inc. published this content on November 19, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on November 19, 2026 at 20:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]